JUNIPER NETWORKS INC, 10-Q filed on 11/2/2020
Quarterly Report
v3.20.2
Cover Page - shares
9 Months Ended
Sep. 30, 2020
Oct. 28, 2020
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2020  
Document Transition Report false  
Entity File Number 001-34501  
Entity Registrant Name JUNIPER NETWORKS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0422528  
Entity Address, Address Line One 1133 Innovation Way  
Entity Address, City or Town Sunnyvale,  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94089  
City Area Code 408  
Local Phone Number 745-2000  
Title of 12(b) Security Common Stock, par value $0.00001 per share  
Trading Symbol JNPR  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   329,736,374
Entity Central Index Key 0001043604  
Amendment Flag false  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --12-31  
v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Total net revenues $ 1,138.2 $ 1,133.1 $ 3,222.5 $ 3,237.3
Cost of revenues:        
Total cost of revenues 480.4 454.7 1,365.8 1,339.8
Gross margin 657.8 678.4 1,856.7 1,897.5
Operating expenses:        
Research and development 242.4 244.5 715.9 716.1
Sales and marketing 229.3 235.3 692.7 692.8
General and administrative 59.8 61.2 178.2 189.4
Restructuring charges (benefits) 1.2 (1.1) 14.9 35.6
Total operating expenses 532.7 539.9 1,601.7 1,633.9
Operating income 125.1 138.5 255.0 263.6
Other expense, net (13.5) (20.4) (29.0) (23.2)
Income before income taxes 111.6 118.1 226.0 240.4
Income tax (benefit) provision (33.8) 18.8 (1.0) 63.8
Net income $ 145.4 $ 99.3 $ 227.0 $ 176.6
Net income per share:        
Basic (in dollars per share) $ 0.44 $ 0.29 $ 0.69 $ 0.51
Diluted, (in dollars per share) $ 0.43 $ 0.29 $ 0.68 $ 0.50
Weighted-average shares used to compute net income per share:        
Basic (in shares) 330.9 342.2 330.9 345.5
Diluted (in shares) 334.5 345.5 335.2 350.1
Product        
Total net revenues $ 733.7 $ 743.2 $ 2,034.8 $ 2,075.8
Cost of revenues:        
Total cost of revenues 327.7 304.0 918.4 888.3
Service        
Total net revenues 404.5 389.9 1,187.7 1,161.5
Cost of revenues:        
Total cost of revenues $ 152.7 $ 150.7 $ 447.4 $ 451.5
v3.20.2
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Statement of Comprehensive Income [Abstract]        
Net income $ 145.4 $ 99.3 $ 227.0 $ 176.6
Available-for-sale debt securities:        
Change in net unrealized gains, net of tax benefit of $0.1and $2.0 during the three and nine months ended September 30, 2020, respectively, and tax provision of zero and $(0.8) for the comparable periods in 2019, respectively 0.5 0.0 6.2 3.8
Net realized gains and losses reclassified into net income, net of tax (0.8) (0.1) (0.5) (0.1)
Net change on available-for-sale debt securities, net of tax (0.3) (0.1) 5.7 3.7
Cash flow hedges:        
Change in net unrealized gains and (losses), net of tax provision of $(5.5) and $(3.1) during the three and nine months ended September 30, 2020, respectively, and tax provision of $(0.2) and $(1.3) for the comparable periods in 2019, respectively 29.8 (12.6) 21.0 (12.3)
Net realized losses reclassified into net income, net of tax benefit of $0.4 and $1.3 during the three and nine months ended September 30, 2020, respectively, and tax provision of $(0.7) and $(1.5) for the comparable periods in 2019, respectively 1.0 1.5 8.5 3.0
Net change on cash flow hedges, net of tax 30.8 (11.1) 29.5 (9.3)
Change in foreign currency translation adjustments 7.6 (4.3) (1.5) (3.0)
Other comprehensive loss, net 38.1 (15.5) 33.7 (8.6)
Comprehensive income $ 183.5 $ 83.8 $ 260.7 $ 168.0
v3.20.2
Condensed Consolidated Statements of Comprehensive Income (Parentheticals) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Statement of Comprehensive Income [Abstract]        
Unrealized gain (loss) on available-for-sale securities, tax benefit (provision) $ 0.1 $ 0.0 $ 2.0 $ (0.8)
Unrealized (loss) gain on cash flow hedges, tax benefit (provision) (5.5) (0.2) (3.1) (1.3)
Reclassification adjustment for realized net loss (gain) on cash flow hedges included in net income, tax benefit (provision) $ 0.4 $ (0.7) $ 1.3 $ (1.5)
v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 1,341.5 $ 1,215.8
Short-term investments 499.3 738.0
Accounts receivable, net of allowances 754.0 879.7
Prepaid expenses and other current assets 443.7 376.3
Total current assets 3,038.5 3,209.8
Property and equipment, net 768.6 830.9
Operating lease assets 172.7 169.7
Long-term investments 720.4 589.8
Purchased intangible assets, net 151.9 185.8
Goodwill 3,337.1 3,337.1
Other long-term assets 505.5 514.6
Total assets 8,694.7 8,837.7
Current liabilities:    
Accounts payable 269.6 219.5
Accrued compensation 197.0 229.0
Deferred revenue 750.2 812.9
Other accrued liabilities 284.8 282.5
Total current liabilities 1,501.6 1,543.9
Long-term debt 1,714.1 1,683.9
Long-term deferred revenue 383.8 410.5
Long-term income taxes payable 308.6 372.6
Long-term operating lease liabilities 159.2 158.1
Other long-term liabilities 66.6 58.1
Total liabilities 4,133.9 4,227.1
Commitments and contingencies (Note 13)
Stockholders' equity:    
Preferred stock, $0.00001 par value; 10.0 shares authorized; none issued and outstanding 0.0 0.0
Common stock, $0.00001 par value; 1,000.0 shares authorized; 329.3 shares and 335.9 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 0.0 0.0
Additional paid-in capital 7,214.8 7,370.5
Accumulated other comprehensive income (loss) 15.2 (18.5)
Accumulated deficit (2,669.2) (2,741.4)
Total stockholders' equity 4,560.8 4,610.6
Total liabilities and stockholders' equity $ 8,694.7 $ 8,837.7
v3.20.2
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Sep. 30, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Preferred stock - par value (in dollars per share) $ 0.00001 $ 0.00001
Preferred stock - shares authorized (shares) 10,000,000.0 10,000,000.0
Preferred stock - issued (shares) 0 0
Preferred stock - outstanding (shares) 0 0
Common stock - par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock - shares authorized (shares) 1,000,000,000.0 1,000,000,000.0
Common stock - issued (shares) 329,300,000 335,900,000
Common stock - outstanding (shares) 329,300,000 335,900,000
v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net income $ 227.0 $ 176.6
Adjustments to reconcile net income to net cash provided by operating activities:    
Share-based compensation expense 138.7 147.1
Depreciation, amortization, and accretion 158.0 155.5
Operating lease assets expense 31.5 32.0
Loss on extinguishment of debt 0.0 15.3
Other 2.6 3.6
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net 126.1 125.2
Prepaid expenses and other assets (43.8) (33.8)
Accounts payable 50.2 19.1
Accrued compensation (31.6) (45.4)
Income taxes payable (60.1) (8.7)
Other accrued liabilities (23.8) (49.5)
Deferred revenue (88.6) (103.8)
Net cash provided by operating activities 486.2 433.2
Cash flows from investing activities:    
Purchases of property and equipment (67.9) (83.5)
Purchases of available-for-sale debt securities (831.9) (2,789.6)
Proceeds from sales of available-for-sale debt securities 198.7 1,035.0
Proceeds from maturities and redemptions of available-for-sale debt securities 746.6 1,410.1
Purchases of equity securities (9.4) (10.2)
Proceeds from sales of equity securities 4.6 5.0
Proceeds from Pulse note receivable 50.0 0.0
Payments for business acquisitions, net of cash and cash equivalents acquired 0.0 (270.9)
Other (4.7) 0.0
Net cash provided by (used in) investing activities 86.0 (704.1)
Cash flows from financing activities:    
Repurchase and retirement of common stock (305.7) (354.9)
Proceeds from issuance of common stock 54.5 55.4
Payment of dividends (198.0) (196.4)
Payment of debt 0.0 (950.0)
Issuance of debt, net 0.0 495.2
Payment for debt extinguishment costs 0.0 (14.6)
Other 4.8 0.0
Net cash used in financing activities (444.4) (965.3)
Effect of foreign currency exchange rates on cash, cash equivalents, and restricted cash (2.5) (3.6)
Net increase (decrease) in cash, cash equivalents, and restricted cash 125.3 (1,239.8)
Cash, cash equivalents, and restricted cash at beginning of period 1,276.5 2,505.8
Cash, cash equivalents, and restricted cash at end of period $ 1,401.8 $ 1,266.0
v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Shares
Common Stock and Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Balance (in shares) at Dec. 31, 2018   346.4          
Balance at Dec. 31, 2018 $ 4,823.2   $ 7,672.8 $ (18.2) $ (2,831.4)    
Balance (Accounting Standards Update 2017-12) at Dec. 31, 2018           $ 0.1 $ 0.1
Balance (Accounting Standards Update 2016-02) at Dec. 31, 2018           $ (4.8) $ (4.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 176.6       176.6    
Other comprehensive income (loss), net (8.6)     (8.6)      
Issuance of common stock (in shares)   8.5          
Issuance of common stock 55.4   55.4        
Common stock assumed upon business combination 4.7   4.7        
Repurchase and retirement of common stock (in shares)   (13.9)          
Repurchase and retirement of common stock (354.9)   (181.7)   (173.2)    
Share-based compensation expense 147.1   147.1        
Payments of cash dividends (196.4)   (196.4)        
Balance (in shares) at Sep. 30, 2019   341.0          
Balance at Sep. 30, 2019 4,642.4   7,501.9 (26.8) (2,832.7)    
Balance (in shares) at Jun. 30, 2019   344.5          
Balance at Jun. 30, 2019 4,591.2   7,491.2 (11.3) (2,888.7)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 99.3       99.3    
Other comprehensive income (loss), net (15.5)     (15.5)      
Issuance of common stock (in shares)   1.7          
Issuance of common stock 25.7   25.7        
Repurchase and retirement of common stock (in shares)   (5.2)          
Repurchase and retirement of common stock (111.1)   (67.8)   (43.3)    
Purchase of forward contract under accelerated share repurchase program ("ASR") 60.0   60.0        
Share-based compensation expense 57.5   57.5        
Payments of cash dividends (64.7)   (64.7)        
Balance (in shares) at Sep. 30, 2019   341.0          
Balance at Sep. 30, 2019 4,642.4   7,501.9 (26.8) (2,832.7)    
Balance (in shares) at Dec. 31, 2019   335.9          
Balance at Dec. 31, 2019 4,610.6   7,370.5 (18.5) (2,741.4)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 227.0       227.0    
Other comprehensive income (loss), net 33.7     33.7      
Issuance of common stock (in shares)   8.2          
Issuance of common stock 54.5   54.5        
Repurchase and retirement of common stock (in shares)   (14.8)          
Repurchase and retirement of common stock (345.7)   (190.9)   (154.8)    
Purchase of forward contract under accelerated share repurchase program ("ASR") 40.0   40.0        
Share-based compensation expense 138.7   138.7        
Payments of cash dividends (198.0)   (198.0)        
Balance (in shares) at Sep. 30, 2020   329.3          
Balance at Sep. 30, 2020 4,560.8   7,214.8 15.2 (2,669.2)    
Balance (in shares) at Jun. 30, 2020   331.7          
Balance at Jun. 30, 2020 4,464.3   7,255.7 (22.9) (2,768.5)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 145.4       145.4    
Other comprehensive income (loss), net 38.1     38.1      
Issuance of common stock (in shares)   1.8          
Issuance of common stock 26.9   26.9        
Repurchase and retirement of common stock (in shares)   (4.2)          
Repurchase and retirement of common stock (100.4)   (54.3)   (46.1)    
Share-based compensation expense 52.7   52.7        
Payments of cash dividends (66.2)   (66.2)        
Balance (in shares) at Sep. 30, 2020   329.3          
Balance at Sep. 30, 2020 $ 4,560.8   $ 7,214.8 $ 15.2 $ (2,669.2)    
v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Statement of Stockholders' Equity [Abstract]        
Cash dividends (in dollars per share) $ 0.20 $ 0.19 $ 0.60 $ 0.57
v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies
Note 1. Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

The Condensed Consolidated Financial Statements of Juniper Networks, Inc. (the “Company” or “Juniper”) were prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all information and footnotes required by U.S. GAAP for complete financial statements. The Condensed Consolidated Balance Sheet as of December 31, 2019 has been derived from the audited Consolidated Financial Statements at that date. In the opinion of management, all adjustments, including normal recurring accruals, considered necessary for a fair presentation have been included. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020, or any future period.

These Condensed Consolidated Financial Statements and accompanying notes should be read in conjunction with the audited Consolidated Financial Statements and accompanying notes in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 (the "Form 10-K"). We have evaluated all subsequent events through the date these condensed consolidated financial statements were issued.

The preparation of the financial statements and related disclosures in accordance with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Actual results could differ materially from those estimates under different assumptions or conditions.

Summary of Significant Accounting Policies

Except for the change in certain policies upon adoption of the accounting standards and the policy for interest rate lock cash flow hedges described below, there have been no significant changes to the Company's significant accounting policies described in Note 2, Significant Accounting Policies, in Notes to Consolidated Financial Statements in Item 8 of Part II of the Form 10-K.

The Company records changes in fair value of interest rate locks in accumulated other comprehensive income (loss) in the consolidated balance sheets, in the period of change. When the forecasted transaction occurs, the Company will start to amortize the accumulated gain or losses included as a component of other comprehensive income (loss) related to the interest rate lock cash flow hedges to interest expense. In the event the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, the gain or loss on the related cash flow hedge from accumulated other comprehensive income (loss) will be reclassified to other income and expense within the income statement.

Recently Adopted Accounting Standards

Fair Value Measurement: On January 1, 2020, the Company adopted ASU No. 2018-13 (Topic 820) Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement, which eliminates, adds, and modifies certain disclosure requirements for fair value measurements under ASC 820. The Company adopted the standard under the prospective approach for certain modified or new disclosure requirements, and all other amendments in the standard under the retrospective approach. See Note 3, Fair Value Measurements for required disclosures.

Simplifying the Test for Goodwill Impairment: On January 1, 2020, the Company adopted ASU No. 2017-04 (Topic 350) Intangibles—Goodwill and Other: Simplifying the Test for Goodwill Impairment, which removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. Under the amended guidance, a goodwill impairment charge will be recognized for the amount by which the carrying value of a reporting unit exceeds its fair value, not to exceed the carrying amount of goodwill. The Company adopted the standard under the prospective approach. Upon adoption, the standard did not have a material impact on the Consolidated Financial Statements.

Credit Losses on Financial Instruments: On January 1, 2020, the Company adopted ASU 2016-13 (Topic 326) Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments, as further clarified by the Financial
Accounting Standards Board (the "FASB") through the issuance of additional related ASUs, which requires the measurement and recognition of current expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss model, which requires the use of forward-looking information to calculate credit loss estimates. It also eliminates the concept of other-than-temporary impairment and requires credit losses related to available-for-sale debt securities to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. These changes will result in earlier recognition of credit losses. The Company adopted the standard under the modified retrospective approach. Upon adoption, the standard did not have a material impact on the Consolidated Financial Statements.

Recent Accounting Standards Not Yet Adopted

Reference Rate Reform: In March 2020, the FASB issued ASU No. 2020-04 (Topic 848), Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides temporary optional expedients and exceptions to the existing guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate (SOFR). The standard was effective upon issuance and may generally be applied through December 31, 2022, to any new or amended contracts, hedging relationships, and other transactions that reference LIBOR. The Company is currently evaluating the impact of the transition and disclosure requirements of the standard on its Consolidated Financial Statements.

Simplifying the Accounting for Income Taxes: In December 2019, the FASB issued ASU No. 2019-12 (Topic 740) Income Taxes — Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects related to accounting for income taxes. This ASU is to be applied on a prospective basis with the exception of certain amendments that are to be applied on either a retrospective or modified retrospective basis. The new standard is effective for interim and annual periods beginning after December 15, 2020. The Company does not expect the adoption to have a material impact on its Consolidated Financial Statements.
v3.20.2
Cash Equivalents and Investments
9 Months Ended
Sep. 30, 2020
Cash Equivalents and Investments [Abstract]  
Cash Equivalents and Investments
Note 2. Cash Equivalents and Investments

Investments in Available-for-Sale Debt Securities

The following table summarizes the Company's unrealized gains and losses and fair value of investments designated as available-for-sale debt securities as of September 30, 2020 and December 31, 2019 (in millions):
As of September 30, 2020As of December 31, 2019
Amortized
Cost
Gross Unrealized
Gains
Gross Unrealized
Losses
Estimated Fair
Value
Amortized
Cost
Gross Unrealized
Gains
Gross Unrealized
Losses
Estimated Fair
Value
Fixed income securities:
Asset-backed securities$74.0 $0.3 $— $74.3 $81.3 $0.1 $— $81.4 
Certificates of deposit31.8 — — 31.8 38.6 — — 38.6 
Commercial paper87.1 — — 87.1 168.2 — — 168.2 
Corporate debt securities672.8 6.4 (0.2)679.0 604.9 0.7 (0.1)605.5 
Foreign government debt securities
8.0 — — 8.0 11.4 — — 11.4 
Time deposits223.6 — — 223.6 226.3 — — 226.3 
U.S. government agency securities
58.3 0.2 — 58.5 89.0 — — 89.0 
U.S. government securities407.1 1.7 — 408.8 394.3 0.3 (0.1)394.5 
Total fixed income securities
1,562.7 8.6 (0.2)1,571.1 1,614.0 1.1 (0.2)1,614.9 
Privately-held debt and redeemable preferred stock securities
19.3 37.4 — 56.7 19.1 37.4 — 56.5 
Total available-for-sale debt securities
$1,582.0 $46.0 $(0.2)$1,627.8 $1,633.1 $38.5 $(0.2)$1,671.4 
Reported as:
Cash equivalents$356.2 $— $— $356.2 $290.9 $— $— $290.9 
Short-term investments492.8 1.7 — 494.5 733.7 0.5 — 734.2 
Long-term investments713.7 6.9 (0.2)720.4 589.4 0.6 (0.2)589.8 
Other long-term assets19.3 37.4 — 56.7 19.1 37.4 — 56.5 
Total$1,582.0 $46.0 $(0.2)$1,627.8 $1,633.1 $38.5 $(0.2)$1,671.4 


The following table presents the contractual maturities of the Company's total fixed income securities as of September 30, 2020 (in millions):
 Amortized
Cost
Estimated Fair
Value
Due in less than one year$849.0 $850.7 
Due between one and five years713.7 720.4 
Total$1,562.7 $1,571.1 
The following tables present the Company's total fixed income securities that were in an unrealized loss position as of September 30, 2020 and December 31, 2019 (in millions):
As of September 30, 2020
 Less than 12 Months12 Months or GreaterTotal
 Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fixed income securities:
Asset-backed securities$10.3 $— $— $— $10.3 $— 
Corporate debt securities105.2 (0.2)— — 105.2 (0.2)
Foreign government debt securities8.0 — — — 8.0 — 
U.S. government securities13.4 — — — 13.4 — 
Total fixed income securities$136.9 $(0.2)$— $— $136.9 $(0.2)
As of December 31, 2019
 Less than 12 Months12 Months or GreaterTotal
 Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fixed income securities:
Asset-backed securities$21.6 $— $5.2 $— $26.8 $— 
Corporate debt securities142.6 (0.1)2.1 — 144.7 (0.1)
Foreign government debt securities4.0 — 4.0 — 8.0 — 
U.S. government agency securities20.0 — — — 20.0 — 
U.S. government securities71.6 (0.1)— — 71.6 (0.1)
Total fixed income securities$259.8 $(0.2)$11.3 $— $271.1 $(0.2)

For available-for-sale debt securities that have unrealized losses, the Company assesses impairment by evaluating various factors, including whether (i) it has the intention to sell any of these investments and (ii) whether it is more likely than not that it will be required to sell any of these investments before recovery of the entire amortized cost basis. The Company periodically assesses performance indicators of the investment by evaluating various factors such as (i) changes in the credit ratings and (ii) review of the issuer. As of September 30, 2020, the Company had 97 investments in unrealized loss positions. The gross unrealized losses related to these investments were primarily due to changes in market interest rates. The Company anticipates that it will recover the entire amortized cost basis of such available-for-sale debt securities and has determined that no allowance for credit losses was required to be recognized during the three and nine months ended September 30, 2020 and September 30, 2019.

During the three and nine months ended September 30, 2020 and September 30, 2019, there were no material gross realized gains or losses from available-for-sale debt securities.
Investments in Equity Securities

The following table presents the Company's investments in equity securities as of September 30, 2020 and December 31, 2019 (in millions):
As of
September 30,
2020
December 31,
2019
Equity investments with readily determinable fair value
Money market funds$580.4 $446.4 
Mutual funds27.1 26.8 
Publicly-traded equity securities4.8 3.8 
Equity investments without readily determinable fair value140.0 133.3 
Total equity securities$752.3 $610.3 
Reported as:
Cash equivalents$576.4 $442.3 
Short-term investments4.8 3.8 
Prepaid expenses and other current assets7.2 4.1 
Other long-term assets163.9 160.1 
Total$752.3 $610.3 

For the three and nine months ended September 30, 2020 and September 30, 2019, there were no material unrealized gains or losses recognized for equity investments.

Restricted Cash and Investments

The Company has restricted cash and investments for: (i) amounts held in escrow accounts, as required in connection with certain acquisitions completed primarily in 2019; (ii) amounts held under the Company's short-term disability plan in California; and (iii) amounts under the Company's non-qualified deferred compensation plan for senior-level employees. Restricted investments consist of equity investments. As of September 30, 2020, the carrying value of restricted cash and investments was $91.4 million, of which $67.4 million was included in prepaid expenses and other current assets, and $24.0 million was included in other long-term assets on the Condensed Consolidated Balance Sheet.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash included in the Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019 (in millions):
As of
September 30,
2020
December 31,
2019
Cash and cash equivalents$1,341.5 $1,215.8 
Restricted cash included in Prepaid expenses and other current assets60.3 60.7 
Total cash, cash equivalents, and restricted cash$1,401.8 $1,276.5 
v3.20.2
Fair Value Measurements
9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Note 3. Fair Value Measurements
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table provides a summary of assets and liabilities measured at fair value on a recurring basis and as reported in the Condensed Consolidated Balance Sheets (in millions):
Fair Value Measurements at
September 30, 2020
Fair Value Measurements at
December 31, 2019
Quoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
TotalQuoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
Total
Assets:
Available-for-sale debt securities:
Asset-backed securities$— $74.3 $— $74.3 $— $81.4 $— $81.4 
Certificates of deposit— 31.8 — 31.8 — 38.6 — 38.6 
Commercial paper— 87.1 — 87.1 — 168.2 — 168.2 
Corporate debt securities — 679.0 — 679.0 — 605.5 — 605.5 
Foreign government debt securities
— 8.0 — 8.0 — 11.4 — 11.4 
Time deposits— 223.6 — 223.6 — 226.3 — 226.3 
U.S. government agency securities
— 58.5 — 58.5 — 89.0 — 89.0 
U.S. government securities
214.2 194.6 — 408.8 318.9 75.6 — 394.5 
Privately-held debt and redeemable preferred stock securities
— — 56.7 56.7 — — 56.5 56.5 
Total available-for-sale debt securities
214.2 1,356.9 56.7 1,627.8 318.9 1,296.0 56.5 1,671.4 
Equity securities:
Money market funds580.4 — — 580.4 446.4 — — 446.4 
Mutual funds27.1 — — 27.1 26.8 — — 26.8 
Publicly-traded equity securities4.8 — — 4.8 3.8 — — 3.8 
Total equity securities
612.3 — — 612.3 477.0 — — 477.0 
Derivative assets:
Foreign exchange contracts
— 20.9 — 20.9 — 2.5 — 2.5 
Interest rate contracts
— 36.8 — 36.8 — — — — 
Total derivative assets
— 57.7 — 57.7 — 2.5 — 2.5 
Total assets measured at fair value on a recurring basis
$826.5 $1,414.6 $56.7 $2,297.8 $795.9 $1,298.5 $56.5 $2,150.9 
Liabilities:
Derivative liabilities:
Foreign exchange contracts
$— $(2.2)$— $(2.2)$— $(6.8)$— $(6.8)
Interest rate contracts
— — — — — (3.1)— (3.1)
Total derivative liabilities
— (2.2)— (2.2)— (9.9)— (9.9)
Total liabilities measured at fair value on a recurring basis
$— $(2.2)$— $(2.2)$— $(9.9)$— $(9.9)
Fair Value Measurements at
September 30, 2020
Fair Value Measurements at
December 31, 2019
Quoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
TotalQuoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
Total
Total assets, reported as:
Cash equivalents$576.4 $356.2 $— $932.6 $442.3 $290.9 $— $733.2 
Short-term investments117.2 382.1 — 499.3 188.8 549.2 — 738.0 
Long-term investments101.8 618.6 — 720.4 133.9 455.9 — 589.8 
Prepaid expenses and other current assets
7.2 12.2 — 19.4 4.1 2.5 — 6.6 
Other long-term assets23.9 45.5 56.7 126.1 26.8 — 56.5 83.3 
Total assets measured at fair value
$826.5 $1,414.6 $56.7 $2,297.8 $795.9 $1,298.5 $56.5 $2,150.9 
Total liabilities, reported as:
Other accrued liabilities$— $(2.0)$— $(2.0)$— $(6.8)$— $(6.8)
Other long-term liabilities— (0.2)— (0.2)— (3.1)— (3.1)
Total liabilities measured at fair value on a recurring basis
$— $(2.2)$— $(2.2)$— $(9.9)$— $(9.9)

The Company's Level 2 available-for-sale debt securities are priced using quoted market prices for similar instruments or non-binding market prices that are corroborated by observable market data. The Company uses inputs such as actual trade data, benchmark yields, broker/dealer quotes, or alternative pricing sources with reasonable levels of price transparency, which are obtained from quoted market prices, independent pricing vendors, or other sources, to determine the ultimate fair value of these assets. The Company's derivative instruments are classified as Level 2, as they are not actively traded and are valued using pricing models that use observable market inputs. During the three and nine months ended September 30, 2020, the Company had no transfers into or out of Level 3 of the fair value hierarchy of its assets or liabilities measured at fair value.

The Company's privately-held debt and redeemable preferred stock securities are classified as Level 3 assets due to the lack of observable inputs to determine fair value. The Company estimates the fair value of its privately-held debt and redeemable preferred stock securities on a recurring basis using an analysis of the financial condition and near-term prospects of the investee, including recent valuations at the time of financing activities and the investee's capital structure. During the three and nine months ended September 30, 2020, there were no significant activities related to privately-held debt and redeemable preferred stock securities.

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis

The Company's investments in equity securities without readily determinable fair value are classified as Level 3 assets due to the lack of observable inputs to determine fair value. The Company estimates the fair value on a nonrecurring basis (i.e. when an observable transaction occurs) using an analysis of the financial condition and near-term prospects of the investee, including recent financing activities and the investee's capital structure. As of September 30, 2020, there have been no material upward or downward adjustments for price changes to the equity securities without readily determinable fair value.

Certain of the Company's assets, including intangible assets and goodwill, are measured at fair value on a nonrecurring basis. There were no significant impairment charges recognized during the three and nine months ended September 30, 2020.

As of September 30, 2020 and December 31, 2019, the Company had no liabilities required to be measured at fair value on a nonrecurring basis.
Assets and Liabilities Not Measured at Fair Value

The carrying amounts of the Company's accounts receivable, accounts payable, and other accrued liabilities approximate fair value due to their short maturities. As of September 30, 2020 and December 31, 2019, the estimated fair value of the Company's total outstanding debt in the Condensed Consolidated Balance Sheets was $1,984.0 million and $1,852.1 million, respectively, based on observable market inputs (Level 2). The carrying value of a contract manufacturer deposit of $58.3 million, reported within other long-term assets, in the Condensed Consolidated Balance Sheets approximates its fair value as of September 30, 2020. See Note 5, Other Financial Information, for further information on the contract manufacturer deposit.

In July 2020, the Company received payment against the promissory note receivable, with a maturity date of September 30, 2022, in connection with the previously completed sale of Junos Pulse. The borrower exercised its prepayment option and paid the outstanding principal of $50.0 million along with the accumulated interest of $37.7 million, aggregating to $87.7 million, in full.
v3.20.2
Derivative Instruments
9 Months Ended
Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Note 4. Derivative Instruments

The Company uses derivative instruments to manage a variety of risks, including risks related to fluctuations in foreign currency exchange rates and interest rates on debt instruments. We do not use derivative financial instruments for speculative purposes.

The notional amount of the Company's derivatives is summarized as follows (in millions):
 As of
 September 30,
2020
December 31,
2019
Designated derivatives:
Cash flow hedges:
Foreign currency contracts
$711.7 $484.0 
Interest rate lock contracts
650.0 — 
Fair value hedges:
Interest rate swap contracts
300.0 300.0 
Total designated derivatives
1,661.7 784.0 
Non-designated derivatives163.3 162.9 
Total$1,825.0 $946.9 

The fair value of derivative instruments on the Consolidated Balance Sheets was as follows:
 As of
 Balance Sheet ClassificationSeptember 30,
2020
December 31,
2019
Derivative assets:
Derivatives designated as hedging instruments:
Foreign currency contracts Other current assets$12.1 $2.2 
Foreign currency contracts Other long-term assets8.7 0.3 
Interest rate lock contracts Other long-term assets10.9 — 
Interest rate swap contractsOther long-term assets25.9 — 
Total derivatives designated as hedging instruments$57.6 $2.5 
Derivatives not designated as hedging instrumentsOther current assets0.1 — 
Total derivative assets$57.7 $2.5 
Derivative liabilities:
Derivatives designated as hedging instruments:
Foreign currency contracts Other accrued liabilities$1.8 $6.6 
Foreign currency contracts Other long-term liabilities0.2 — 
Interest rate swap contractsOther long-term liabilities— 3.1 
Total derivatives designated as hedging instruments$2.0 $9.7 
Derivatives not designated as hedging instrumentsOther accrued liabilities0.2 0.2 
Total derivative liabilities$2.2 $9.9 
Designated Derivatives

The Company uses foreign currency forward contracts to hedge the Company's planned cost of revenues and operating expenses denominated in foreign currencies. These derivatives are designated as cash flow hedges and typically have maturities of thirty-six months or less.

In 2020, the Company entered into interest rate locks with large financial institutions, which fix the benchmark interest rates of future debt issuance for an aggregate notional amount of $650.0 million. These contracts are designated as cash flow hedges and are expected to terminate within 5 years.

In 2019, the Company entered into interest rate swaps with an aggregate notional amount of $300.0 million designated as fair value hedges of our fixed-rate 2041 Notes. These swaps convert the fixed interest rates of the notes to floating interest rates based on the LIBOR. Most of the interest rate swaps will expire within nine years or less.

Effect of Derivative Instruments on the Consolidated Statements of Operations

For cash flow hedges, the Company recognized an unrealized gain of $35.3 million and $24.1 million in accumulated other comprehensive income for the effective portion of its derivative instruments for the three and nine months ended September 30, 2020, respectively. The Company recognized an unrealized loss of $12.4 million and $11.1 million in accumulated other comprehensive income for the effective portion of its derivative instruments for the three and nine months ended September 30, 2019, respectively.

For foreign currency forward contracts, the Company reclassified a loss of $1.4 million and $9.8 million out of accumulated other comprehensive income to cost of revenues and operating expenses in the Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2020, respectively, and a loss of $0.8 million and $1.5 million for the comparable periods ended September 30, 2019, respectively. As of September 30, 2020, an estimated $10.2 million of unrealized net gain within accumulated other comprehensive loss is expected to be reclassified into earnings within the next twelve months.

Non-Designated Derivatives

The Company also uses foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. These foreign exchange forward contracts typically have maturities of approximately one to four months. The outstanding non-designated derivative instruments are carried at fair value. Changes in the fair value of these derivatives, which were recorded in other expense, net within the Condensed Consolidated Statements of Operations, were not material during the three and nine months ended September 30, 2020 and September 30, 2019.
v3.20.2
Other Financial Information
9 Months Ended
Sep. 30, 2020
Other Financial Information [Abstract]  
Other Financial Information
Note 5. Other Financial Information

Inventory

Total inventory consisted of the following (in millions):
As of
September 30,
2020
December 31,
2019
Production and service materials$144.6 $69.0 
Finished goods31.2 25.2 
Inventory$175.8 $94.2 
Reported as:
Prepaid expenses and other current assets$166.4 $90.6 
Other long-term assets9.4 3.6 
Total$175.8 $94.2 

Deposit

The Company has a non-interest bearing deposit balance of $58.3 million, net of an unamortized discount balance of $3.0 million, to a contract manufacturer. The discount is calculated based on an imputed interest rate of 5.0% at September 30, 2020. The imputed interest will be amortized over the term of the deposit to interest income along with a corresponding charge to cost of revenues. The deposit is classified as other long-term assets on the Condensed Consolidated Balance Sheets.

Warranties

Changes during the nine months ended September 30, 2020 in the Company’s warranty reserve as reported within other accrued liabilities in the Condensed Consolidated Balance Sheets were as follows (in millions):
Balance as of December 31, 2019$31.4 
Provisions made during the period28.1 
Actual costs incurred during the period(28.9)
Balance as of September 30, 2020$30.6 
Deferred Revenue

Details of the Company's deferred revenue, as reported in the Condensed Consolidated Balance Sheets, were as follows (in millions):
As of
September 30,
2020
December 31,
2019
Deferred product revenue:
Undelivered product commitments and other product deferrals$109.8 $141.7 
Deferred gross product revenue109.8 141.7 
Deferred cost of product revenue(10.5)(9.1)
Deferred product revenue, net99.3 132.6 
Deferred service revenue1,034.7 1,090.8 
Total$1,134.0 $1,223.4 
Reported as:
Current$750.2 $812.9 
Long-term383.8 410.5 
Total$1,134.0 $1,223.4 

Revenue

See Note 10, Segments, for disaggregated revenue by product and service, customer vertical, and geographic region.

Product revenue of $13.3 million and $61.7 million included in deferred revenue at January 1, 2020 was recognized during the three and nine months ended September 30, 2020, respectively. Service revenue of $149.6 million and $622.6 million included in deferred revenue at January 1, 2020 was recognized during the three and nine months ended September 30, 2020, respectively.

The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of September 30, 2020 and when the Company expects to recognize the amounts as revenue (in millions):
Revenue Recognition Expected by Period
TotalLess than 1 year1-3 yearsMore than 3 years
Product$109.8 $90.4 $17.3 $2.1 
Service(*)
1,049.0 677.5 308.2 63.3 
Total$1,158.8 $767.9 $325.5 $65.4 
________________________________
(*)     Represents unearned service revenue allocated to the performance obligations not delivered or partially delivered as of September 30, 2020. The unearned service revenue is comprised of deferred revenue and non-cancellable contract revenue for which we have not invoiced.

Deferred Commissions

Deferred commissions were $26.2 million as of September 30, 2020. For the three and nine months ended September 30, 2020, amortization expense for the deferred commissions was $35.1 million and $92.7 million, respectively, and there were no impairment charges recognized.
Other Expense, Net

Other expense, net, consisted of the following (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Interest income $6.1 $19.7 $30.4 $63.0 
Interest expense(19.1)(22.1)(58.5)(68.3)
Loss on extinguishment of debt— (15.3)— (15.3)
Gain (loss) on investments, net2.0 (3.4)2.7 (4.6)
Other(2.5)0.7 (3.6)2.0 
Other expense, net$(13.5)$(20.4)$(29.0)$(23.2)
v3.20.2
Restructuring Charges
9 Months Ended
Sep. 30, 2020
Restructuring and Related Activities [Abstract]  
Restructuring Charges
Note 6. Restructuring Charges

During the first quarter of 2020, the Company initiated a restructuring plan (the "2020 Restructuring Plan") designed to realign its workforce with the Company's sales strategy, enhance productivity and cost efficiencies, and enable reinvestment in certain key priority areas. In connection with the 2020 Restructuring Plan, during the three months ended September 30, 2020, the Company recorded $1.2 million in severance costs; during the nine months ended September 30, 2020, the Company recorded $9.6 million in severance and $5.3 million in impairment charges included in other exit related costs, which were reported as restructuring charges in the Condensed Consolidated Statements of Operations.

Restructuring liabilities are reported within other accrued liabilities in the Condensed Consolidated Balance Sheets. The following table provides a summary of changes in the restructuring liabilities for the Company's 2020 and prior year restructuring plan (in millions):
December 31,
2019
ChargesCash
Payments

Other
September 30,
2020
Severance$0.7 $9.6 $(7.0)$— $3.3 
Other— 5.3 — (5.3)— 
Total$0.7 $14.9 $(7.0)$(5.3)$3.3 

The Company expects to substantially pay the remaining restructuring liabilities by the end of the fourth quarter of 2020.
v3.20.2
Debt
9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Debt
Note 7. Debt

Debt

The following table summarizes the Company's total debt (in millions, except percentages):
 As of September 30, 2020
 Issuance dateMaturity DateAmountEffective Interest
Rates
Senior Notes ("Notes"):
4.500% fixed-rate notes ("2024 Notes")
March 2014March 2024$350.0 4.63 %
4.500% fixed-rate notes ("2024 Notes")
February 2016March 2024150.0 4.87 %
4.350% fixed-rate notes ("2025 Notes")
March 2015June 2025300.0 4.47 %
3.750% fixed-rate notes ("2029 Notes")
August 2019August 2029500.0 3.86 %
5.950% fixed-rate notes ("2041 Notes")
March 2011March 2041400.0 6.03 %
Total Notes1,700.0 
Unaccreted discount and debt issuance costs(11.8)
Hedge accounting fair value adjustments(*)
25.9 
Total$1,714.1 
________________________________
(*)     Represents the fair value adjustments for interest rate swaps with an aggregate notional amount of $300.0 million designated as fair value hedges of our fixed-rate 2041 Notes. See Note 4, Derivative Instruments, for a discussion of the Company's interest rate swaps.

The Notes above are the Company’s senior unsecured and unsubordinated obligations, ranking equally in right of payment to all of the Company’s existing and future senior unsecured and unsubordinated indebtedness, and senior in right of payment to any of the Company’s future indebtedness that is expressly subordinated to the Notes.

Interest on the Notes is payable in cash semiannually. The effective interest rates for the Notes include the interest on the Notes, accretion of the discount, and amortization of issuance costs. The indentures that govern the Notes also contain various covenants, including limitations on the Company's ability to incur liens or enter into sale-leaseback transactions over certain dollar thresholds.

As of September 30, 2020, the Company was in compliance with all covenants in the indentures governing the Notes.

Revolving Credit Facility

The Company has an unsecured revolving credit facility that will expire in April 2024, which enables borrowings of up to $500.0 million, with an option to increase the amount of the credit facility by up to an additional $200.0 million, subject to the lenders' approval. The credit facility will terminate in April 2024, subject to a one-year maturity extension option. As of September 30, 2020, the Company was in compliance with all covenants and no amounts were outstanding under our credit facility.
v3.20.2
Equity
9 Months Ended
Sep. 30, 2020
Stockholders' Equity Note [Abstract]  
Equity
Note 8. Equity

The following table summarizes dividends paid, stock repurchases, and retirements under the Company's stock repurchase program (in millions, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Dividends
Per share
$0.20 $0.19 $0.60 $0.57 
Amount
$66.2 $64.7 $197.9 $196.4 
Repurchased under the 2018 Stock Repurchase Program
Shares
4.2 5.1 14.5 13.7 
Average price per share(*)
$23.93 $24.90 $23.86 $25.45 
Amount
$100.0 $50.0 $300.0 $350.0 
________________________________
(*)    During the three months ended September 30, 2020, the $23.93 average price per share includes $100.0 million in open market purchases. During the nine months ended September 30, 2020, the $23.86 average price per share includes $300.0 million in open market purchases, and settlement of the forward contract of $40.0 million under the ASR, which was initiated during the fourth quarter of 2019. During the three and nine months ended September 30, 2019, the $24.90 and $25.45 average price per share includes the forward contract of $60.0 million under the ASR, which was initiated and settled during the second and the third quarter of 2019, respectively.

Cash Dividends on Shares of Common Stock

During the three and nine months ended September 30, 2020, the Company declared a quarterly cash dividend of $0.20 per share of common stock on January 27, 2020, April 28, 2020 and July 28, 2020, respectively, which was paid on March 23, 2020, June 22, 2020 and September 22, 2020, respectively, to stockholders of record on March 2, 2020, June 1, 2020 and September 1, 2020, respectively. Any future dividends, and the establishment of record and payment dates, are subject to approval by the Board of Directors (the “Board”) of Juniper or an authorized committee thereof. See Note 14, Subsequent Events, for discussion of the Company's dividend declaration subsequent to September 30, 2020.

Stock Repurchase Activities

In January 2018, the Board approved a $2.0 billion share repurchase program ("2018 Stock Repurchase Program"), which replaced our prior authorization. In October 2019, the Board authorized a $1.0 billion increase to the 2018 Stock Repurchase Program for a total of $3.0 billion.

In October 2019, the Company entered into an ASR, to repurchase an aggregate of $200.0 million of the Company’s outstanding common stock. During the three months ended December 31, 2019, the Company made an up-front payment of $200.0 million pursuant to the ASR and received and retired an initial 6.4 million shares of the Company’s common stock for an aggregate price of $160.0 million, based on the market price of $25.15 per share of the Company’s common stock on the date of the transaction. During the three months ended March 31, 2020, the ASR was completed, and an additional 1.8 million shares were received for a total repurchase of 8.2 million shares of the Company's common stock at a volume weighted average repurchase price, less an agreed upon discount, of $24.44 per share. The shares received by the Company were retired, accounted for as a reduction to stockholder’s equity in the Condensed Consolidated Balance Sheets, and treated as a repurchase of common stock for purposes of calculating earnings per share.

During the nine months ended September 30, 2020, the Company repurchased 14.5 million shares of its common stock in the open market for an aggregate purchase price of $300.0 million at an average price of $23.86 per share, under the 2018 Stock Repurchase Program.
As of September 30, 2020, there was approximately $1.4 billion of authorized funds remaining under the 2018 Stock Repurchase Program.

Future share repurchases under the 2018 Stock Repurchase Program will be subject to a review of the circumstances at that time and will be made from time to time in private transactions or open market purchases as permitted by securities laws and other legal requirements. The Company's 2018 Stock Repurchase Program may be discontinued at any time.

In addition to repurchases under the 2018 Stock Repurchase Program, the Company also withholds shares of common stock from certain employees in connection with the vesting of stock awards issued to such employees to satisfy applicable tax withholding requirements. Such withheld shares are treated as common stock repurchases in our financial statements as they reduce the number of shares that would have been issued upon vesting. Repurchases associated with tax withholdings were not material during the three and nine months ended September 30, 2020 and September 30, 2019.

Accumulated Other Comprehensive Loss, Net of Tax

The components of accumulated other comprehensive loss, net of related taxes, for the nine months ended September 30, 2020 were as follows (in millions):
Unrealized
Gains/Losses
on Available-for-
Sale Debt Securities
Unrealized
Gains/Losses
on Cash Flow
Hedges
Foreign
Currency
Translation
Adjustments
Total
Balance as of December 31, 2019$29.7 $(4.3)$(43.9)$(18.5)
Other comprehensive loss before reclassifications6.2 21.0 (1.5)25.7 
Amount reclassified from accumulated other comprehensive loss
(0.5)8.5 — 8.0 
Other comprehensive loss, net 5.7 29.5 (1.5)33.7 
Balance as of September 30, 2020$35.4 $25.2 $(45.4)$15.2 
v3.20.2
Employee Benefit Plans
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Employee Benefit Plans
Note 9. Employee Benefit Plans

Equity Incentive Plans

The Company has stock-based compensation plans pursuant to which it has granted stock options, restricted stock units (“RSUs”), and performance share awards (“PSAs”). The Company also maintains its 2008 Employee Stock Purchase Plan (the “ESPP”) for all eligible employees. As of September 30, 2020, 12.4 million and 11.5 million shares were available for future issuance under the Company's 2015 Equity Incentive Plan (the "2015 Plan") and the ESPP, respectively. In connection with past acquisitions, the Company has also assumed or substituted stock options, RSUs, restricted stock awards ("RSAs"), and PSAs.

RSU, RSA and PSA Activities

The Company’s RSU, RSA and PSA activity and related information as of and for the nine months ended September 30, 2020 were as follows (in millions, except per share amounts and years):
Outstanding RSUs, RSAs and PSAs
Number of SharesWeighted Average
Grant-Date Fair
Value per Share
Weighted Average
Remaining
Contractual Term
(In Years)
Aggregate
Intrinsic
Value
Balance as of December 31, 201917.5 $25.30 
Granted(*)
7.4 22.32 
Vested(5.9)25.95 
Canceled(2.0)25.22 
Balance as of September 30, 202017.0 $23.79 1.2$364.9 
________________________________
(*)    Includes 6.2 million service-based, 0.8 million performance-based, and 0.4 million market-based RSUs and PSAs, as applicable. The number of shares subject to performance-based and market-based conditions represents the aggregate maximum number of shares that may be issued pursuant to the award over its full term. The grant date fair value of RSUs and PSAs was reduced by the present value of dividends expected to be paid on the underlying shares of common stock during the requisite and derived service period as these awards are not entitled to receive dividends until vested.

Employee Stock Purchase Plan

The following table summarizes employee stock purchases through the ESPP (in millions, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Shares purchased1.3 1.2 2.7 2.4 
Average exercise price per share$19.68 $22.03 $19.59 $22.04 

The ESPP provides a 24-month offering period with four 6-month purchase periods. A new 24-month offering period commences every six months. The purchase price for the Company’s common stock under the ESPP is 85% of the lower of the fair market value of the shares at (1) the beginning of the applicable offering period or (2) the end of each 6-month purchase period during such offering period. The ESPP will continue in effect until February 25, 2028, unless terminated earlier under the provisions of the ESPP.
Share-Based Compensation Expense

Share-based compensation expense associated with stock options, RSUs, RSAs, PSAs, and the ESPP was recorded in the following cost and expense categories in the Condensed Consolidated Statements of Operations (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Cost of revenues - Product$1.4 $0.8 $3.9 $4.3 
Cost of revenues - Service4.0 4.1 11.6 13.0 
Research and development22.9 29.6 57.1 68.0 
Sales and marketing16.4 15.5 43.4 40.0 
General and administrative8.0 7.5 22.7 21.8 
Total$52.7 $57.5 $138.7 $147.1 

The following table summarizes share-based compensation expense by award type (in millions):
 Three Months Ended September 30,Nine Months Ended September 30,
 2020201920202019
Stock options$1.5 $2.3 $5.2 $5.6 
RSUs, RSAs, and PSAs45.8 50.9 118.0 127.7 
ESPP5.4 4.3 15.5 13.8 
Total$52.7 $57.5 $138.7 $147.1 
As of September 30, 2020, the total unrecognized compensation cost related to unvested share-based awards was $288.4 million to be recognized over a weighted-average period of 1.68 years.
v3.20.2
Segments
9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Segments
Note 10. Segments

The Company operates in one reportable segment. The Company's chief executive officer, who is the chief operating decision maker, reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance, accompanied by disaggregated information about net revenues by product and service, customer vertical, and geographic region as presented below.

The following table presents net revenues by product and service (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Routing$432.0 $407.5 $1,149.7 $1,199.1 
Switching229.0 241.6 657.6 633.6 
Security72.7 94.1 227.5 243.1 
Total product 733.7 743.2 2,034.8 2,075.8 
Total service404.5 389.9 1,187.7 1,161.5 
Total $1,138.2 $1,133.1 $3,222.5 $3,237.3 

The following table presents net revenues by customer vertical (in millions):
 Three Months Ended September 30,Nine Months Ended September 30,
 2020201920202019
Cloud$253.1 $271.9 $800.5 $780.0 
Service Provider475.1 452.5 1,286.8 1,335.3 
Enterprise410.0 408.7 1,135.2 1,122.0 
Total$1,138.2 $1,133.1 $3,222.5 $3,237.3 

The Company attributes revenues to geographic region based on the customer’s shipping address. The following table presents net revenues by geographic region (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Americas:
United States$575.0 $599.4 $1,651.7 $1,677.2 
Other49.3 49.4 160.9 164.0 
Total Americas624.3 648.8 1,812.6 1,841.2 
Europe, Middle East, and Africa321.1 301.5 870.2 879.6 
Asia Pacific192.8 182.8 539.7 516.5 
Total$1,138.2 $1,133.1 $3,222.5 $3,237.3 
v3.20.2
Income Taxes
9 Months Ended
Sep. 30, 2020
Income Tax Disclosure [Abstract]  
Income Taxes
Note 11. Income Taxes

The following table provides details of income taxes (in millions, except percentages):
 Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Income before income taxes$111.6 $118.1 $226.0 $240.4 
Income tax (benefit) provision$(33.8)$18.8 $(1.0)$63.8 
Effective tax rate(30.3)%15.9 %(0.4)%26.5 %

The Company’s effective tax rate differs from the federal statutory rate of 21% primarily due to the tax impact of state taxes, geographic mix of earnings including foreign-derived intangible income deductions and global intangible low-taxed income, research and development ("R&D") tax credits, tax audit settlements, nondeductible compensation, cost sharing of stock-based compensation, and other transfer pricing adjustments.

In the third quarter of 2020, the Company received final orders from the U.S. and India Competent Authorities, which resolved the Company’s dispute with the India Tax Authorities for the 2010 through 2012 income tax years. The Company also remeasured certain previously unrecognized tax benefits for all open years resulting in a total release of $54.5 million, including $18.4 million of interest and penalties.

The Company’s effective tax rate for the nine months ended September 30, 2020 reflects the cumulative recognition of previously unrecognized tax benefits for transfer pricing of $54.5 million referenced above.

On June 7, 2019, the Ninth Circuit Court of Appeals issued an opinion in Altera Corp. v. Commissioner requiring related parties in an intercompany cost-sharing arrangement to share expenses related to stock-based compensation. On February 10, 2020, Altera appealed this decision to the U.S. Supreme Court, which on June 22, 2020, declined to review the decision. Based on the Supreme Court decision to not review the Ninth Circuit Court’s decision, stock-based compensation is subject to cost sharing, and the Company recorded a $18.2 million charge.

The Company's effective tax rate for the nine months ended September 30, 2019 reflected the recognition of previously unrecognized tax benefits, due to a lapse in statutes of limitation.

As of September 30, 2020, the total amount of gross unrecognized tax benefits was $112.2 million.
The Company engages in continuous discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. There is a greater than remote likelihood that the balance of the gross unrecognized tax benefits will decrease by up to $11.6 million within the next twelve months due to the completion of tax review cycles in various tax jurisdictions and lapses of applicable statutes of limitation.
v3.20.2
Net Income Per Share
9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Net Income Per Share
Note 12. Net Income per Share

The Company computed basic and diluted net income per share as follows (in millions, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Numerator:
Net income
$145.4 $99.3 $227.0 $176.6 
Denominator:
Weighted-average shares used to compute basic net income per share
330.9 342.2 330.9 345.5 
Dilutive effect of employee stock awards3.6 3.3 4.3 4.6 
Weighted-average shares used to compute diluted net income per share
334.5 345.5 335.2 350.1 
Net income per share
Basic$0.44 $0.29 $0.69 $0.51 
Diluted$0.43 $0.29 $0.68 $0.50 
Anti-dilutive shares 3.4 2.8 5.5 2.7 
v3.20.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 13. Commitments and Contingencies

Commitments

Except for the items below, there have been no material changes to the Company's commitments compared to the commitments described in Note 16, Commitments and Contingencies, in Notes to Consolidated Financial Statements in Item 8 of Part II of the Form 10-K.

Unconditional Purchase Obligations

Unconditional purchase obligations consist of agreements that include firm and non-cancelable terms to transfer funds in the future for fixed or minimum amounts or quantities to be purchased at fixed or minimum prices. During the second quarter of 2020, the Company amended its existing Master Services Agreement and certain Statements of Work (collectively, the "Agreement") with International Business Machines Corporation ("IBM") related to IT outsourcing services, resulting in a $79.4 million reduction in fees payable to IBM over the remaining initial term of the Agreement.

Purchase Commitments with Contract Manufacturers and Suppliers

In order to reduce manufacturing lead times and in the interest of having access to adequate component supply, the Company enters into agreements with contract manufacturers and certain suppliers to procure inventory based on the Company's requirements. A significant portion of the Company's purchase commitments arising from these agreements consists of firm and non-cancelable commitments. These purchase commitments totaled $1,402.5 million as of September 30, 2020.

The Company establishes a liability in connection with purchase commitments related to quantities in excess of its demand forecasts or obsolete materials charges for components purchased by the contract manufacturers based on the Company’s demand forecast or customer orders. As of September 30, 2020, the Company had accrued $18.5 million based on its estimate of such charges.

Legal Proceedings

In the ordinary course of business, the Company is subject to various pending and potential investigations, disputes, litigations, and legal proceedings. The Company records an accrual for loss contingencies for legal proceedings when it believes that an unfavorable outcome is both (a) probable and (b) the amount or range of any possible loss is reasonably estimable. The Company intends to aggressively defend itself in any legal matters, and while the outcome of any pending matters is not currently determinable, the Company believes that none of its currently existing claims or proceedings are likely to have a material adverse effect on its financial position. Notwithstanding the foregoing, there are many uncertainties associated with any litigation and these matters or any other third-party claims against the Company may cause the Company to incur costly litigation and/or substantial settlement charges. In addition, the resolution of any intellectual property litigation may require the Company to make royalty payments, which could adversely affect gross margins in future periods. If any of these events were to occur, the Company's business, financial condition, results of operations, and cash flows could be adversely affected. The actual liability in any such matters may be materially different from the Company's estimates, if any, which could result in the need to adjust the liability and record additional expenses.
v3.20.2
Subsequent Events
9 Months Ended
Sep. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events
Note 14. Subsequent Events

128 Technology Acquisition

In October 2020, the Company announced and entered into a definitive agreement to acquire 128 Technology for approximately $450.0 million, subject to customary adjustments, cash and the assumption of outstanding equity awards. We expect that the acquisition will enhance Juniper's AI-driven enterprise network portfolio by uniting 128 Technology’s session-smart networking with Juniper's campus and branch solutions driven by Mist AI. The acquisition is expected to close in the fourth quarter of 2020, subject to regulatory approvals and other customary closing conditions.

Netrounds Acquisition

On October 26, 2020, the Company completed the acquisition of Netrounds, a company that provides a programmable, software-based active test and service assurance platform suitable for fixed and mobile networks, for approximately $35.0 million in cash, subject to adjustments for cash on hand, indebtedness, and certain other closing adjustments. Netrounds will enhance Juniper’s automated WAN solutions by further simplifying operations for service providers and ensuring positive end-user experiences.

Dividend Declaration

On October 27, 2020, the Company announced that the Board declared a cash dividend of $0.20 per share of common stock to be paid on December 22, 2020 to stockholders of record as of the close of business on December 1, 2020.
v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

The Condensed Consolidated Financial Statements of Juniper Networks, Inc. (the “Company” or “Juniper”) were prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all information and footnotes required by U.S. GAAP for complete financial statements. The Condensed Consolidated Balance Sheet as of December 31, 2019 has been derived from the audited Consolidated Financial Statements at that date. In the opinion of management, all adjustments, including normal recurring accruals, considered necessary for a fair presentation have been included. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020, or any future period.

These Condensed Consolidated Financial Statements and accompanying notes should be read in conjunction with the audited Consolidated Financial Statements and accompanying notes in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 (the "Form 10-K"). We have evaluated all subsequent events through the date these condensed consolidated financial statements were issued.
Use of Estimates The preparation of the financial statements and related disclosures in accordance with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Actual results could differ materially from those estimates under different assumptions or conditions.
Derivatives The Company records changes in fair value of interest rate locks in accumulated other comprehensive income (loss) in the consolidated balance sheets, in the period of change. When the forecasted transaction occurs, the Company will start to amortize the accumulated gain or losses included as a component of other comprehensive income (loss) related to the interest rate lock cash flow hedges to interest expense. In the event the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, the gain or loss on the related cash flow hedge from accumulated other comprehensive income (loss) will be reclassified to other income and expense within the income statement.
Recently Adopted Accounting Standards and Recent Accounting Standards Not Yet Adopted
Recently Adopted Accounting Standards

Fair Value Measurement: On January 1, 2020, the Company adopted ASU No. 2018-13 (Topic 820) Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement, which eliminates, adds, and modifies certain disclosure requirements for fair value measurements under ASC 820. The Company adopted the standard under the prospective approach for certain modified or new disclosure requirements, and all other amendments in the standard under the retrospective approach. See Note 3, Fair Value Measurements for required disclosures.

Simplifying the Test for Goodwill Impairment: On January 1, 2020, the Company adopted ASU No. 2017-04 (Topic 350) Intangibles—Goodwill and Other: Simplifying the Test for Goodwill Impairment, which removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. Under the amended guidance, a goodwill impairment charge will be recognized for the amount by which the carrying value of a reporting unit exceeds its fair value, not to exceed the carrying amount of goodwill. The Company adopted the standard under the prospective approach. Upon adoption, the standard did not have a material impact on the Consolidated Financial Statements.

Credit Losses on Financial Instruments: On January 1, 2020, the Company adopted ASU 2016-13 (Topic 326) Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments, as further clarified by the Financial
Accounting Standards Board (the "FASB") through the issuance of additional related ASUs, which requires the measurement and recognition of current expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss model, which requires the use of forward-looking information to calculate credit loss estimates. It also eliminates the concept of other-than-temporary impairment and requires credit losses related to available-for-sale debt securities to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. These changes will result in earlier recognition of credit losses. The Company adopted the standard under the modified retrospective approach. Upon adoption, the standard did not have a material impact on the Consolidated Financial Statements.

Recent Accounting Standards Not Yet Adopted

Reference Rate Reform: In March 2020, the FASB issued ASU No. 2020-04 (Topic 848), Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides temporary optional expedients and exceptions to the existing guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate (SOFR). The standard was effective upon issuance and may generally be applied through December 31, 2022, to any new or amended contracts, hedging relationships, and other transactions that reference LIBOR. The Company is currently evaluating the impact of the transition and disclosure requirements of the standard on its Consolidated Financial Statements.

Simplifying the Accounting for Income Taxes: In December 2019, the FASB issued ASU No. 2019-12 (Topic 740) Income Taxes — Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects related to accounting for income taxes. This ASU is to be applied on a prospective basis with the exception of certain amendments that are to be applied on either a retrospective or modified retrospective basis. The new standard is effective for interim and annual periods beginning after December 15, 2020. The Company does not expect the adoption to have a material impact on its Consolidated Financial Statements.
v3.20.2
Cash Equivalents and Investments (Tables)
9 Months Ended
Sep. 30, 2020
Cash Equivalents and Investments [Abstract]  
Unrealized gains and losses and fair value of available-for-sale debt securities
The following table summarizes the Company's unrealized gains and losses and fair value of investments designated as available-for-sale debt securities as of September 30, 2020 and December 31, 2019 (in millions):
As of September 30, 2020As of December 31, 2019
Amortized
Cost
Gross Unrealized
Gains
Gross Unrealized
Losses
Estimated Fair
Value
Amortized
Cost
Gross Unrealized
Gains
Gross Unrealized
Losses
Estimated Fair
Value
Fixed income securities:
Asset-backed securities$74.0 $0.3 $— $74.3 $81.3 $0.1 $— $81.4 
Certificates of deposit31.8 — — 31.8 38.6 — — 38.6 
Commercial paper87.1 — — 87.1 168.2 — — 168.2 
Corporate debt securities672.8 6.4 (0.2)679.0 604.9 0.7 (0.1)605.5 
Foreign government debt securities
8.0 — — 8.0 11.4 — — 11.4 
Time deposits223.6 — — 223.6 226.3 — — 226.3 
U.S. government agency securities
58.3 0.2 — 58.5 89.0 — — 89.0 
U.S. government securities407.1 1.7 — 408.8 394.3 0.3 (0.1)394.5 
Total fixed income securities
1,562.7 8.6 (0.2)1,571.1 1,614.0 1.1 (0.2)1,614.9 
Privately-held debt and redeemable preferred stock securities
19.3 37.4 — 56.7 19.1 37.4 — 56.5 
Total available-for-sale debt securities
$1,582.0 $46.0 $(0.2)$1,627.8 $1,633.1 $38.5 $(0.2)$1,671.4 
Reported as:
Cash equivalents$356.2 $— $— $356.2 $290.9 $— $— $290.9 
Short-term investments492.8 1.7 — 494.5 733.7 0.5 — 734.2 
Long-term investments713.7 6.9 (0.2)720.4 589.4 0.6 (0.2)589.8 
Other long-term assets19.3 37.4 — 56.7 19.1 37.4 — 56.5 
Total$1,582.0 $46.0 $(0.2)$1,627.8 $1,633.1 $38.5 $(0.2)$1,671.4 
Maturities of fixed income securities
The following table presents the contractual maturities of the Company's total fixed income securities as of September 30, 2020 (in millions):
 Amortized
Cost
Estimated Fair
Value
Due in less than one year$849.0 $850.7 
Due between one and five years713.7 720.4 
Total$1,562.7 $1,571.1 
Available-for-sale securities in unrealized loss position
The following tables present the Company's total fixed income securities that were in an unrealized loss position as of September 30, 2020 and December 31, 2019 (in millions):
As of September 30, 2020
 Less than 12 Months12 Months or GreaterTotal
 Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fixed income securities:
Asset-backed securities$10.3 $— $— $— $10.3 $— 
Corporate debt securities105.2 (0.2)— — 105.2 (0.2)
Foreign government debt securities8.0 — — — 8.0 — 
U.S. government securities13.4 — — — 13.4 — 
Total fixed income securities$136.9 $(0.2)$— $— $136.9 $(0.2)
As of December 31, 2019
 Less than 12 Months12 Months or GreaterTotal
 Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fixed income securities:
Asset-backed securities$21.6 $— $5.2 $— $26.8 $— 
Corporate debt securities142.6 (0.1)2.1 — 144.7 (0.1)
Foreign government debt securities4.0 — 4.0 — 8.0 — 
U.S. government agency securities20.0 — — — 20.0 — 
U.S. government securities71.6 (0.1)— — 71.6 (0.1)
Total fixed income securities$259.8 $(0.2)$11.3 $— $271.1 $(0.2)
Schedule of investments in equity securities
The following table presents the Company's investments in equity securities as of September 30, 2020 and December 31, 2019 (in millions):
As of
September 30,
2020
December 31,
2019
Equity investments with readily determinable fair value
Money market funds$580.4 $446.4 
Mutual funds27.1 26.8 
Publicly-traded equity securities4.8 3.8 
Equity investments without readily determinable fair value140.0 133.3 
Total equity securities$752.3 $610.3 
Reported as:
Cash equivalents$576.4 $442.3 
Short-term investments4.8 3.8 
Prepaid expenses and other current assets7.2 4.1 
Other long-term assets163.9 160.1 
Total$752.3 $610.3 
Schedule of reconciliation of cash, cash equivalents and restricted cash
The following table provides a reconciliation of cash, cash equivalents, and restricted cash included in the Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019 (in millions):
As of
September 30,
2020
December 31,
2019
Cash and cash equivalents$1,341.5 $1,215.8 
Restricted cash included in Prepaid expenses and other current assets60.3 60.7 
Total cash, cash equivalents, and restricted cash$1,401.8 $1,276.5 
v3.20.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Assets and liabilities measured at fair value on a recurring basis
The following table provides a summary of assets and liabilities measured at fair value on a recurring basis and as reported in the Condensed Consolidated Balance Sheets (in millions):
Fair Value Measurements at
September 30, 2020
Fair Value Measurements at
December 31, 2019
Quoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
TotalQuoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
Total
Assets:
Available-for-sale debt securities:
Asset-backed securities$— $74.3 $— $74.3 $— $81.4 $— $81.4 
Certificates of deposit— 31.8 — 31.8 — 38.6 — 38.6 
Commercial paper— 87.1 — 87.1 — 168.2 — 168.2 
Corporate debt securities — 679.0 — 679.0 — 605.5 — 605.5 
Foreign government debt securities
— 8.0 — 8.0 — 11.4 — 11.4 
Time deposits— 223.6 — 223.6 — 226.3 — 226.3 
U.S. government agency securities
— 58.5 — 58.5 — 89.0 — 89.0 
U.S. government securities
214.2 194.6 — 408.8 318.9 75.6 — 394.5 
Privately-held debt and redeemable preferred stock securities
— — 56.7 56.7 — — 56.5 56.5 
Total available-for-sale debt securities
214.2 1,356.9 56.7 1,627.8 318.9 1,296.0 56.5 1,671.4 
Equity securities:
Money market funds580.4 — — 580.4 446.4 — — 446.4 
Mutual funds27.1 — — 27.1 26.8 — — 26.8 
Publicly-traded equity securities4.8 — — 4.8 3.8 — — 3.8 
Total equity securities
612.3 — — 612.3 477.0 — — 477.0 
Derivative assets:
Foreign exchange contracts
— 20.9 — 20.9 — 2.5 — 2.5 
Interest rate contracts
— 36.8 — 36.8 — — — — 
Total derivative assets
— 57.7 — 57.7 — 2.5 — 2.5 
Total assets measured at fair value on a recurring basis
$826.5 $1,414.6 $56.7 $2,297.8 $795.9 $1,298.5 $56.5 $2,150.9 
Liabilities:
Derivative liabilities:
Foreign exchange contracts
$— $(2.2)$— $(2.2)$— $(6.8)$— $(6.8)
Interest rate contracts
— — — — — (3.1)— (3.1)
Total derivative liabilities
— (2.2)— (2.2)— (9.9)— (9.9)
Total liabilities measured at fair value on a recurring basis
$— $(2.2)$— $(2.2)$— $(9.9)$— $(9.9)
Fair Value Measurements at
September 30, 2020
Fair Value Measurements at
December 31, 2019
Quoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
TotalQuoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
Total
Total assets, reported as:
Cash equivalents$576.4 $356.2 $— $932.6 $442.3 $290.9 $— $733.2 
Short-term investments117.2 382.1 — 499.3 188.8 549.2 — 738.0 
Long-term investments101.8 618.6 — 720.4 133.9 455.9 — 589.8 
Prepaid expenses and other current assets
7.2 12.2 — 19.4 4.1 2.5 — 6.6 
Other long-term assets23.9 45.5 56.7 126.1 26.8 — 56.5 83.3 
Total assets measured at fair value
$826.5 $1,414.6 $56.7 $2,297.8 $795.9 $1,298.5 $56.5 $2,150.9 
Total liabilities, reported as:
Other accrued liabilities$— $(2.0)$— $(2.0)$— $(6.8)$— $(6.8)
Other long-term liabilities— (0.2)— (0.2)— (3.1)— (3.1)
Total liabilities measured at fair value on a recurring basis
$— $(2.2)$— $(2.2)$— $(9.9)$— $(9.9)
v3.20.2
Derivative Instruments (Tables)
9 Months Ended
Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative instruments
The notional amount of the Company's derivatives is summarized as follows (in millions):
 As of
 September 30,
2020
December 31,
2019
Designated derivatives:
Cash flow hedges:
Foreign currency contracts
$711.7 $484.0 
Interest rate lock contracts
650.0 — 
Fair value hedges:
Interest rate swap contracts
300.0 300.0 
Total designated derivatives
1,661.7 784.0 
Non-designated derivatives163.3 162.9 
Total$1,825.0 $946.9 
Schedule of Derivative Assets at Fair Value
The fair value of derivative instruments on the Consolidated Balance Sheets was as follows:
 As of
 Balance Sheet ClassificationSeptember 30,
2020
December 31,
2019
Derivative assets:
Derivatives designated as hedging instruments:
Foreign currency contracts Other current assets$12.1 $2.2 
Foreign currency contracts Other long-term assets8.7 0.3 
Interest rate lock contracts Other long-term assets10.9 — 
Interest rate swap contractsOther long-term assets25.9 — 
Total derivatives designated as hedging instruments$57.6 $2.5 
Derivatives not designated as hedging instrumentsOther current assets0.1 — 
Total derivative assets$57.7 $2.5 
Derivative liabilities:
Derivatives designated as hedging instruments:
Foreign currency contracts Other accrued liabilities$1.8 $6.6 
Foreign currency contracts Other long-term liabilities0.2 — 
Interest rate swap contractsOther long-term liabilities— 3.1 
Total derivatives designated as hedging instruments$2.0 $9.7 
Derivatives not designated as hedging instrumentsOther accrued liabilities0.2 0.2 
Total derivative liabilities$2.2 $9.9 
Schedule of Derivative Liabilities at Fair Value
The fair value of derivative instruments on the Consolidated Balance Sheets was as follows:
 As of
 Balance Sheet ClassificationSeptember 30,
2020
December 31,
2019
Derivative assets:
Derivatives designated as hedging instruments:
Foreign currency contracts Other current assets$12.1 $2.2 
Foreign currency contracts Other long-term assets8.7 0.3 
Interest rate lock contracts Other long-term assets10.9 — 
Interest rate swap contractsOther long-term assets25.9 — 
Total derivatives designated as hedging instruments$57.6 $2.5 
Derivatives not designated as hedging instrumentsOther current assets0.1 — 
Total derivative assets$57.7 $2.5 
Derivative liabilities:
Derivatives designated as hedging instruments:
Foreign currency contracts Other accrued liabilities$1.8 $6.6 
Foreign currency contracts Other long-term liabilities0.2 — 
Interest rate swap contractsOther long-term liabilities— 3.1 
Total derivatives designated as hedging instruments$2.0 $9.7 
Derivatives not designated as hedging instrumentsOther accrued liabilities0.2 0.2 
Total derivative liabilities$2.2 $9.9 
v3.20.2
Other Financial Information (Tables)
9 Months Ended
Sep. 30, 2020
Other Financial Information [Abstract]  
Inventories
Total inventory consisted of the following (in millions):
As of
September 30,
2020
December 31,
2019
Production and service materials$144.6 $69.0 
Finished goods31.2 25.2 
Inventory$175.8 $94.2 
Reported as:
Prepaid expenses and other current assets$166.4 $90.6 
Other long-term assets9.4 3.6 
Total$175.8 $94.2 
Warranties
Changes during the nine months ended September 30, 2020 in the Company’s warranty reserve as reported within other accrued liabilities in the Condensed Consolidated Balance Sheets were as follows (in millions):
Balance as of December 31, 2019$31.4 
Provisions made during the period28.1 
Actual costs incurred during the period(28.9)
Balance as of September 30, 2020$30.6 
Deferred revenue
Details of the Company's deferred revenue, as reported in the Condensed Consolidated Balance Sheets, were as follows (in millions):
As of
September 30,
2020
December 31,
2019
Deferred product revenue:
Undelivered product commitments and other product deferrals$109.8 $141.7 
Deferred gross product revenue109.8 141.7 
Deferred cost of product revenue(10.5)(9.1)
Deferred product revenue, net99.3 132.6 
Deferred service revenue1,034.7 1,090.8 
Total$1,134.0 $1,223.4 
Reported as:
Current$750.2 $812.9 
Long-term383.8 410.5 
Total$1,134.0 $1,223.4 
Performance obligation
The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of September 30, 2020 and when the Company expects to recognize the amounts as revenue (in millions):
Revenue Recognition Expected by Period
TotalLess than 1 year1-3 yearsMore than 3 years
Product$109.8 $90.4 $17.3 $2.1 
Service(*)
1,049.0 677.5 308.2 63.3 
Total$1,158.8 $767.9 $325.5 $65.4 
________________________________
(*)     Represents unearned service revenue allocated to the performance obligations not delivered or partially delivered as of September 30, 2020. The unearned service revenue is comprised of deferred revenue and non-cancellable contract revenue for which we have not invoiced.
Other income (expense), net
Other expense, net, consisted of the following (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Interest income $6.1 $19.7 $30.4 $63.0 
Interest expense(19.1)(22.1)(58.5)(68.3)
Loss on extinguishment of debt— (15.3)— (15.3)
Gain (loss) on investments, net2.0 (3.4)2.7 (4.6)
Other(2.5)0.7 (3.6)2.0 
Other expense, net$(13.5)$(20.4)$(29.0)$(23.2)
v3.20.2
Restructuring (Benefits) Charges (Tables)
9 Months Ended
Sep. 30, 2020
Restructuring and Related Activities [Abstract]  
Schedule of restructuring liabilities The following table provides a summary of changes in the restructuring liabilities for the Company's 2020 and prior year restructuring plan (in millions):
December 31,
2019
ChargesCash
Payments

Other
September 30,
2020
Severance$0.7 $9.6 $(7.0)$— $3.3 
Other— 5.3 — (5.3)— 
Total$0.7 $14.9 $(7.0)$(5.3)$3.3 
v3.20.2
Debt (Tables)
9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Summary of total debt
The following table summarizes the Company's total debt (in millions, except percentages):
 As of September 30, 2020
 Issuance dateMaturity DateAmountEffective Interest
Rates
Senior Notes ("Notes"):
4.500% fixed-rate notes ("2024 Notes")
March 2014March 2024$350.0 4.63 %
4.500% fixed-rate notes ("2024 Notes")
February 2016March 2024150.0 4.87 %
4.350% fixed-rate notes ("2025 Notes")
March 2015June 2025300.0 4.47 %
3.750% fixed-rate notes ("2029 Notes")
August 2019August 2029500.0 3.86 %
5.950% fixed-rate notes ("2041 Notes")
March 2011March 2041400.0 6.03 %
Total Notes1,700.0 
Unaccreted discount and debt issuance costs(11.8)
Hedge accounting fair value adjustments(*)
25.9 
Total$1,714.1 
________________________________
(*)     Represents the fair value adjustments for interest rate swaps with an aggregate notional amount of $300.0 million designated as fair value hedges of our fixed-rate 2041 Notes. See Note 4, Derivative Instruments, for a discussion of the Company's interest rate swaps.
v3.20.2
Equity (Tables)
9 Months Ended
Sep. 30, 2020
Stockholders' Equity Note [Abstract]  
Summary of dividends paid and stock repurchases and retirements under stock repurchase program
The following table summarizes dividends paid, stock repurchases, and retirements under the Company's stock repurchase program (in millions, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Dividends
Per share
$0.20 $0.19 $0.60 $0.57 
Amount
$66.2 $64.7 $197.9 $196.4 
Repurchased under the 2018 Stock Repurchase Program
Shares
4.2 5.1 14.5 13.7 
Average price per share(*)
$23.93 $24.90 $23.86 $25.45 
Amount
$100.0 $50.0 $300.0 $350.0 
________________________________
(*)    During the three months ended September 30, 2020, the $23.93 average price per share includes $100.0 million in open market purchases. During the nine months ended September 30, 2020, the $23.86 average price per share includes $300.0 million in open market purchases, and settlement of the forward contract of $40.0 million under the ASR, which was initiated during the fourth quarter of 2019. During the three and nine months ended September 30, 2019, the $24.90 and $25.45 average price per share includes the forward contract of $60.0 million under the ASR, which was initiated and settled during the second and the third quarter of 2019, respectively.
Components of accumulated other comprehensive loss, net of taxes
The components of accumulated other comprehensive loss, net of related taxes, for the nine months ended September 30, 2020 were as follows (in millions):
Unrealized
Gains/Losses
on Available-for-
Sale Debt Securities
Unrealized
Gains/Losses
on Cash Flow
Hedges
Foreign
Currency
Translation
Adjustments
Total
Balance as of December 31, 2019$29.7 $(4.3)$(43.9)$(18.5)
Other comprehensive loss before reclassifications6.2 21.0 (1.5)25.7 
Amount reclassified from accumulated other comprehensive loss
(0.5)8.5 — 8.0 
Other comprehensive loss, net 5.7 29.5 (1.5)33.7 
Balance as of September 30, 2020$35.4 $25.2 $(45.4)$15.2 
v3.20.2
Employee Benefit Plans (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of nonvested share activity
The Company’s RSU, RSA and PSA activity and related information as of and for the nine months ended September 30, 2020 were as follows (in millions, except per share amounts and years):
Outstanding RSUs, RSAs and PSAs
Number of SharesWeighted Average
Grant-Date Fair
Value per Share
Weighted Average
Remaining
Contractual Term
(In Years)
Aggregate
Intrinsic
Value
Balance as of December 31, 201917.5 $25.30 
Granted(*)
7.4 22.32 
Vested(5.9)25.95 
Canceled(2.0)25.22 
Balance as of September 30, 202017.0 $23.79 1.2$364.9 
________________________________
(*)    Includes 6.2 million service-based, 0.8 million performance-based, and 0.4 million market-based RSUs and PSAs, as applicable. The number of shares subject to performance-based and market-based conditions represents the aggregate maximum number of shares that may be issued pursuant to the award over its full term. The grant date fair value of RSUs and PSAs was reduced by the present value of dividends expected to be paid on the underlying shares of common stock during the requisite and derived service period as these awards are not entitled to receive dividends until vested.
Schedule of employee stock purchases through ESPP
The following table summarizes employee stock purchases through the ESPP (in millions, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Shares purchased1.3 1.2 2.7 2.4 
Average exercise price per share$19.68 $22.03 $19.59 $22.04 
Schedule of employee service share-based compensation, allocation of recognized period costs
Share-based compensation expense associated with stock options, RSUs, RSAs, PSAs, and the ESPP was recorded in the following cost and expense categories in the Condensed Consolidated Statements of Operations (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Cost of revenues - Product$1.4 $0.8 $3.9 $4.3 
Cost of revenues - Service4.0 4.1 11.6 13.0 
Research and development22.9 29.6 57.1 68.0 
Sales and marketing16.4 15.5 43.4 40.0 
General and administrative8.0 7.5 22.7 21.8 
Total$52.7 $57.5 $138.7 $147.1 
Disclosure of share-based compensation arrangements by share-based payment award
The following table summarizes share-based compensation expense by award type (in millions):
 Three Months Ended September 30,Nine Months Ended September 30,
 2020201920202019
Stock options$1.5 $2.3 $5.2 $5.6 
RSUs, RSAs, and PSAs45.8 50.9 118.0 127.7 
ESPP5.4 4.3 15.5 13.8 
Total$52.7 $57.5 $138.7 $147.1 
v3.20.2
Segments (Tables)
9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Financial information for each segment
The following table presents net revenues by product and service (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Routing$432.0 $407.5 $1,149.7 $1,199.1 
Switching229.0 241.6 657.6 633.6 
Security72.7 94.1 227.5 243.1 
Total product 733.7 743.2 2,034.8 2,075.8 
Total service404.5 389.9 1,187.7 1,161.5 
Total $1,138.2 $1,133.1 $3,222.5 $3,237.3 

The following table presents net revenues by customer vertical (in millions):
 Three Months Ended September 30,Nine Months Ended September 30,
 2020201920202019
Cloud$253.1 $271.9 $800.5 $780.0 
Service Provider475.1 452.5 1,286.8 1,335.3 
Enterprise410.0 408.7 1,135.2 1,122.0 
Total$1,138.2 $1,133.1 $3,222.5 $3,237.3 
Net revenues by geographic region
The Company attributes revenues to geographic region based on the customer’s shipping address. The following table presents net revenues by geographic region (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Americas:
United States$575.0 $599.4 $1,651.7 $1,677.2 
Other49.3 49.4 160.9 164.0 
Total Americas624.3 648.8 1,812.6 1,841.2 
Europe, Middle East, and Africa321.1 301.5 870.2 879.6 
Asia Pacific192.8 182.8 539.7 516.5 
Total$1,138.2 $1,133.1 $3,222.5 $3,237.3 
v3.20.2
Income Taxes (Tables)
9 Months Ended
Sep. 30, 2020
Income Tax Disclosure [Abstract]  
Schedule of effective income tax rate reconciliation
The following table provides details of income taxes (in millions, except percentages):
 Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Income before income taxes$111.6 $118.1 $226.0 $240.4 
Income tax (benefit) provision$(33.8)$18.8 $(1.0)$63.8 
Effective tax rate(30.3)%15.9 %(0.4)%26.5 %
v3.20.2
Net Income Per Share (Tables)
9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Schedule of basic and diluted net income per share
The Company computed basic and diluted net income per share as follows (in millions, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Numerator:
Net income
$145.4 $99.3 $227.0 $176.6 
Denominator:
Weighted-average shares used to compute basic net income per share
330.9 342.2 330.9 345.5 
Dilutive effect of employee stock awards3.6 3.3 4.3 4.6 
Weighted-average shares used to compute diluted net income per share
334.5 345.5 335.2 350.1 
Net income per share
Basic$0.44 $0.29 $0.69 $0.51 
Diluted$0.43 $0.29 $0.68 $0.50 
Anti-dilutive shares 3.4 2.8 5.5 2.7 
v3.20.2
Cash Equivalents and Investments - Available-For-Sale (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Available-for-sale debt securities:    
Amortized Cost $ 1,582.0 $ 1,633.1
Gross Unrealized Gains 46.0 38.5
Gross Unrealized Losses (0.2) (0.2)
Estimated Fair Value 1,627.8 1,671.4
Asset-backed securities    
Available-for-sale debt securities:    
Amortized Cost 74.0 81.3
Gross Unrealized Gains 0.3 0.1
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 74.3 81.4
Certificates of deposit    
Available-for-sale debt securities:    
Amortized Cost 31.8 38.6
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 31.8 38.6
Commercial paper    
Available-for-sale debt securities:    
Amortized Cost 87.1 168.2
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 87.1 168.2
Corporate debt securities    
Available-for-sale debt securities:    
Amortized Cost 672.8 604.9
Gross Unrealized Gains 6.4 0.7
Gross Unrealized Losses (0.2) (0.1)
Estimated Fair Value 679.0 605.5
Foreign government debt securities    
Available-for-sale debt securities:    
Amortized Cost 8.0 11.4
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 8.0 11.4
Time deposits    
Available-for-sale debt securities:    
Amortized Cost 223.6 226.3
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 223.6 226.3
U.S. government agency securities    
Available-for-sale debt securities:    
Amortized Cost 58.3 89.0
Gross Unrealized Gains 0.2 0.0
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 58.5 89.0
U.S. government securities    
Available-for-sale debt securities:    
Amortized Cost 407.1 394.3
Gross Unrealized Gains 1.7 0.3
Gross Unrealized Losses 0.0 (0.1)
Estimated Fair Value 408.8 394.5
Fixed Income securities    
Available-for-sale debt securities:    
Amortized Cost 1,562.7 1,614.0
Gross Unrealized Gains 8.6 1.1
Gross Unrealized Losses (0.2) (0.2)
Estimated Fair Value 1,571.1 1,614.9
Privately-held debt and redeemable preferred stock securities    
Available-for-sale debt securities:    
Amortized Cost 19.3 19.1
Gross Unrealized Gains 37.4 37.4
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 56.7 56.5
Cash equivalents    
Available-for-sale debt securities:    
Amortized Cost 356.2 290.9
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 356.2 290.9
Short-term investments    
Available-for-sale debt securities:    
Amortized Cost 492.8 733.7
Gross Unrealized Gains 1.7 0.5
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 494.5 734.2
Long-term investments    
Available-for-sale debt securities:    
Amortized Cost 713.7 589.4
Gross Unrealized Gains 6.9 0.6
Gross Unrealized Losses (0.2) (0.2)
Estimated Fair Value 720.4 589.8
Other long-term assets    
Available-for-sale debt securities:    
Amortized Cost 19.3 19.1
Gross Unrealized Gains 37.4 37.4
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value $ 56.7 $ 56.5
v3.20.2
Cash Equivalents and Investments - Maturities of Fixed Income Securities (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Amortized Cost    
Amortized Cost $ 1,582.0 $ 1,633.1
Estimated Fair Value    
Total 1,627.8 1,671.4
Fixed Income Securities    
Amortized Cost    
Due in less than one year 849.0  
Due between one and five years 713.7  
Amortized Cost 1,562.7 1,614.0
Estimated Fair Value    
Due in less than one year 850.7  
Due between one and five years 720.4  
Total $ 1,571.1 $ 1,614.9
v3.20.2
Cash Equivalents and Investments - Unrealized Loss Position on Fixed Income Securities (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Unrealized Loss    
Less than 12 months, fair value $ 136.9 $ 259.8
Less than 12 months, unrealized loss (0.2) (0.2)
12 months or greater, fair value 0.0 11.3
12 months or greater, unrealized loss 0.0 0.0
Total, fair value 136.9 271.1
Total, unrealized loss (0.2) (0.2)
Asset-backed securities    
Unrealized Loss    
Less than 12 months, fair value 10.3 21.6
Less than 12 months, unrealized loss 0.0 0.0
12 months or greater, fair value 0.0 5.2
12 months or greater, unrealized loss 0.0 0.0
Total, fair value 10.3 26.8
Total, unrealized loss 0.0 0.0
Corporate debt securities    
Unrealized Loss    
Less than 12 months, fair value 105.2 142.6
Less than 12 months, unrealized loss (0.2) (0.1)
12 months or greater, fair value 0.0 2.1
12 months or greater, unrealized loss 0.0 0.0
Total, fair value 105.2 144.7
Total, unrealized loss (0.2) (0.1)
Foreign government debt securities    
Unrealized Loss    
Less than 12 months, fair value 8.0 4.0
Less than 12 months, unrealized loss 0.0 0.0
12 months or greater, fair value 0.0 4.0
12 months or greater, unrealized loss 0.0 0.0
Total, fair value 8.0 8.0
Total, unrealized loss 0.0 0.0
U.S. government agency securities    
Unrealized Loss    
Less than 12 months, fair value   20.0
Less than 12 months, unrealized loss   0.0
12 months or greater, fair value   0.0
12 months or greater, unrealized loss   0.0
Total, fair value   20.0
Total, unrealized loss   0.0
U.S. government securities    
Unrealized Loss    
Less than 12 months, fair value 13.4 71.6
Less than 12 months, unrealized loss 0.0 (0.1)
12 months or greater, fair value 0.0 0.0
12 months or greater, unrealized loss 0.0 0.0
Total, fair value 13.4 71.6
Total, unrealized loss $ 0.0 $ (0.1)
v3.20.2
Cash Equivalents and Investments - Narrative (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2020
USD ($)
Investment
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Investment
Sep. 30, 2019
USD ($)
Restricted Cash and Cash Equivalents Items [Line Items]        
Total investments in unrealized loss position | Investment 97   97  
Available-for-sale debt securities, gross realized gain $ 0 $ 0 $ 0 $ 0
Available-for-sale debt securities, gross realized loss 0 0 0 0
Equity investments, unrealized gains 0 0 0 0
Equity investments, unrealized losses 0 0 0 0
Restricted cash and investments 91,400,000   91,400,000  
Prepaid expenses and other current assets        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted cash and investments 67,400,000   67,400,000  
Other long-term assets        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted cash and investments 24,000,000.0   24,000,000.0  
Debt Securities        
Restricted Cash and Cash Equivalents Items [Line Items]        
Allowance for credit losses $ 0 $ 0 $ 0 $ 0
v3.20.2
Cash Equivalents and Investments - Investments in Equity Securities (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Equity investments without readily determinable fair value $ 140.0 $ 133.3
Total equity securities 752.3 610.3
Cash equivalents    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Total equity securities 576.4 442.3
Short-term investments    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Total equity securities 4.8 3.8
Prepaid expenses and other current assets    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Total equity securities 7.2 4.1
Other long-term assets    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Total equity securities 163.9 160.1
Money market funds    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Equity investments with readily determinable fair value 580.4 446.4
Mutual funds    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Equity investments with readily determinable fair value 27.1 26.8
Publicly-traded equity securities    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Equity investments with readily determinable fair value $ 4.8 $ 3.8
v3.20.2
Cash Equivalents and Investments - Restricted Cash and Investments (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2018
Restricted Cash and Cash Equivalents Items [Line Items]        
Cash and cash equivalents $ 1,341.5 $ 1,215.8    
Total cash, cash equivalents, and restricted cash 1,401.8 1,276.5 $ 1,266.0 $ 2,505.8
Prepaid expenses and other current assets        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted cash included in Prepaid expenses and other current assets $ 60.3 $ 60.7    
v3.20.2
Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Available-for-sale debt securities:    
Available-for-sale debt securities $ 1,627.8 $ 1,671.4
Derivative assets:    
Derivative assets: 57.7 2.5
Asset-backed securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 74.3 81.4
Certificates of deposit    
Available-for-sale debt securities:    
Available-for-sale debt securities 31.8 38.6
Commercial paper    
Available-for-sale debt securities:    
Available-for-sale debt securities 87.1 168.2
Corporate debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 679.0 605.5
Foreign government debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 8.0 11.4
Time deposits    
Available-for-sale debt securities:    
Available-for-sale debt securities 223.6 226.3
U.S. government agency securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 58.5 89.0
U.S. government securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 408.8 394.5
Privately-held debt and redeemable preferred stock securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 56.7 56.5
Money market funds    
Equity securities:    
Equity securities 580.4 446.4
Publicly-traded equity securities    
Equity securities:    
Equity securities 4.8 3.8
Fair Value, Measurements, Recurring    
Available-for-sale debt securities:    
Available-for-sale debt securities 1,627.8 1,671.4
Equity securities:    
Equity securities 612.3 477.0
Derivative assets:    
Derivative assets: 57.7 2.5
Total assets measured at fair value on a recurring basis 2,297.8 2,150.9
Liabilities measured at fair value:    
Derivative liabilities: (2.2) (9.9)
Total liabilities measured at fair value on a recurring basis (2.2) (9.9)
Fair Value, Measurements, Recurring | Foreign exchange contracts    
Derivative assets:    
Derivative assets: 20.9 2.5
Liabilities measured at fair value:    
Derivative liabilities: (2.2) (6.8)
Fair Value, Measurements, Recurring | Interest rate contracts    
Derivative assets:    
Derivative assets: 36.8 0.0
Liabilities measured at fair value:    
Derivative liabilities: 0.0 (3.1)
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 214.2 318.9
Equity securities:    
Equity securities 612.3 477.0
Derivative assets:    
Derivative assets: 0.0 0.0
Total assets measured at fair value on a recurring basis 826.5 795.9
Liabilities measured at fair value:    
Derivative liabilities: 0.0 0.0
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Foreign exchange contracts    
Derivative assets:    
Derivative assets: 0.0 0.0
Liabilities measured at fair value:    
Derivative liabilities: 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Interest rate contracts    
Derivative assets:    
Derivative assets: 0.0 0.0
Liabilities measured at fair value:    
Derivative liabilities: 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 1,356.9 1,296.0
Equity securities:    
Equity securities 0.0 0.0
Derivative assets:    
Derivative assets: 57.7 2.5
Total assets measured at fair value on a recurring basis 1,414.6 1,298.5
Liabilities measured at fair value:    
Derivative liabilities: (2.2) (9.9)
Total liabilities measured at fair value on a recurring basis (2.2) (9.9)
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Foreign exchange contracts    
Derivative assets:    
Derivative assets: 20.9 2.5
Liabilities measured at fair value:    
Derivative liabilities: (2.2) (6.8)
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Interest rate contracts    
Derivative assets:    
Derivative assets: 36.8 0.0
Liabilities measured at fair value:    
Derivative liabilities: 0.0 (3.1)
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 56.7 56.5
Equity securities:    
Equity securities 0.0 0.0
Derivative assets:    
Derivative assets: 0.0 0.0
Total assets measured at fair value on a recurring basis 56.7 56.5
Liabilities measured at fair value:    
Derivative liabilities: 0.0 0.0
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Foreign exchange contracts    
Derivative assets:    
Derivative assets: 0.0 0.0
Liabilities measured at fair value:    
Derivative liabilities: 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Interest rate contracts    
Derivative assets:    
Derivative assets: 0.0 0.0
Liabilities measured at fair value:    
Derivative liabilities: 0.0 0.0
Fair Value, Measurements, Recurring | Asset-backed securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 74.3 81.4
Fair Value, Measurements, Recurring | Asset-backed securities | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Asset-backed securities | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 74.3 81.4
Fair Value, Measurements, Recurring | Asset-backed securities | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Certificates of deposit    
Available-for-sale debt securities:    
Available-for-sale debt securities 31.8 38.6
Fair Value, Measurements, Recurring | Certificates of deposit | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Certificates of deposit | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 31.8 38.6
Fair Value, Measurements, Recurring | Certificates of deposit | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Commercial paper    
Available-for-sale debt securities:    
Available-for-sale debt securities 87.1 168.2
Fair Value, Measurements, Recurring | Commercial paper | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Commercial paper | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 87.1 168.2
Fair Value, Measurements, Recurring | Commercial paper | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Corporate debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 679.0 605.5
Fair Value, Measurements, Recurring | Corporate debt securities | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Corporate debt securities | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 679.0 605.5
Fair Value, Measurements, Recurring | Corporate debt securities | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Foreign government debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 8.0 11.4
Fair Value, Measurements, Recurring | Foreign government debt securities | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Foreign government debt securities | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 8.0 11.4
Fair Value, Measurements, Recurring | Foreign government debt securities | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Time deposits    
Available-for-sale debt securities:    
Available-for-sale debt securities 223.6 226.3
Fair Value, Measurements, Recurring | Time deposits | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Time deposits | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 223.6 226.3
Fair Value, Measurements, Recurring | Time deposits | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | U.S. government agency securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 58.5 89.0
Fair Value, Measurements, Recurring | U.S. government agency securities | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | U.S. government agency securities | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 58.5 89.0
Fair Value, Measurements, Recurring | U.S. government agency securities | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | U.S. government securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 408.8 394.5
Fair Value, Measurements, Recurring | U.S. government securities | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 214.2 318.9
Fair Value, Measurements, Recurring | U.S. government securities | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 194.6 75.6
Fair Value, Measurements, Recurring | U.S. government securities | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Privately-held debt and redeemable preferred stock securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 56.7 56.5
Fair Value, Measurements, Recurring | Privately-held debt and redeemable preferred stock securities | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Privately-held debt and redeemable preferred stock securities | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Privately-held debt and redeemable preferred stock securities | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 56.7 56.5
Fair Value, Measurements, Recurring | Money market funds    
Equity securities:    
Equity securities 580.4 446.4
Fair Value, Measurements, Recurring | Money market funds | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Equity securities:    
Equity securities 580.4 446.4
Fair Value, Measurements, Recurring | Money market funds | Significant Other Observable Remaining Inputs (Level 2)    
Equity securities:    
Equity securities 0.0 0.0
Fair Value, Measurements, Recurring | Money market funds | Significant Other Unobservable Remaining Inputs (Level 3)    
Equity securities:    
Equity securities 0.0 0.0
Fair Value, Measurements, Recurring | Mutual funds    
Equity securities:    
Equity securities 27.1 26.8
Fair Value, Measurements, Recurring | Mutual funds | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Equity securities:    
Equity securities 27.1 26.8
Fair Value, Measurements, Recurring | Mutual funds | Significant Other Observable Remaining Inputs (Level 2)    
Equity securities:    
Equity securities 0.0 0.0
Fair Value, Measurements, Recurring | Mutual funds | Significant Other Unobservable Remaining Inputs (Level 3)    
Equity securities:    
Equity securities 0.0 0.0
Fair Value, Measurements, Recurring | Publicly-traded equity securities    
Equity securities:    
Equity securities 4.8 3.8
Fair Value, Measurements, Recurring | Publicly-traded equity securities | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Equity securities:    
Equity securities 4.8 3.8
Fair Value, Measurements, Recurring | Publicly-traded equity securities | Significant Other Observable Remaining Inputs (Level 2)    
Equity securities:    
Equity securities 0.0 0.0
Fair Value, Measurements, Recurring | Publicly-traded equity securities | Significant Other Unobservable Remaining Inputs (Level 3)    
Equity securities:    
Equity securities 0.0 0.0
Cash equivalents    
Available-for-sale debt securities:    
Available-for-sale debt securities 356.2 290.9
Cash equivalents | Fair Value, Measurements, Recurring    
Derivative assets:    
Total assets measured at fair value on a recurring basis 932.6 733.2
Cash equivalents | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 576.4 442.3
Cash equivalents | Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 356.2 290.9
Cash equivalents | Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 0.0 0.0
Short-term investments    
Available-for-sale debt securities:    
Available-for-sale debt securities 494.5 734.2
Short-term investments | Fair Value, Measurements, Recurring    
Derivative assets:    
Total assets measured at fair value on a recurring basis 499.3 738.0
Short-term investments | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 117.2 188.8
Short-term investments | Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 382.1 549.2
Short-term investments | Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 0.0 0.0
Long-term investments    
Available-for-sale debt securities:    
Available-for-sale debt securities 720.4 589.8
Long-term investments | Fair Value, Measurements, Recurring    
Derivative assets:    
Total assets measured at fair value on a recurring basis 720.4 589.8
Long-term investments | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 101.8 133.9
Long-term investments | Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 618.6 455.9
Long-term investments | Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 0.0 0.0
Prepaid expenses and other current assets | Fair Value, Measurements, Recurring    
Derivative assets:    
Total assets measured at fair value on a recurring basis 19.4 6.6
Prepaid expenses and other current assets | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 7.2 4.1
Prepaid expenses and other current assets | Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 12.2 2.5
Prepaid expenses and other current assets | Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 0.0 0.0
Other long-term assets | Fair Value, Measurements, Recurring    
Derivative assets:    
Total assets measured at fair value on a recurring basis 126.1 83.3
Other long-term assets | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 23.9 26.8
Other long-term assets | Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 45.5 0.0
Other long-term assets | Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3)    
Derivative assets:    
Total assets measured at fair value on a recurring basis 56.7 56.5
Other accrued liabilities | Fair Value, Measurements, Recurring    
Liabilities measured at fair value:    
Total liabilities measured at fair value on a recurring basis (2.0) (6.8)
Other accrued liabilities | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Liabilities measured at fair value:    
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Other accrued liabilities | Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2)    
Liabilities measured at fair value:    
Total liabilities measured at fair value on a recurring basis (2.0) (6.8)
Other accrued liabilities | Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3)    
Liabilities measured at fair value:    
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Other long-term liabilities | Fair Value, Measurements, Recurring    
Liabilities measured at fair value:    
Total liabilities measured at fair value on a recurring basis (0.2) (3.1)
Other long-term liabilities | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Liabilities measured at fair value:    
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Other long-term liabilities | Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2)    
Liabilities measured at fair value:    
Total liabilities measured at fair value on a recurring basis (0.2) (3.1)
Other long-term liabilities | Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3)    
Liabilities measured at fair value:    
Total liabilities measured at fair value on a recurring basis $ 0.0 $ 0.0
v3.20.2
Fair Value Measurements - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2020
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Equity securities without readily determinable fair value, upward adjustment       $ 0    
Equity securities without readily determinable fair value, downward adjustment       0    
Goodwill and intangible impairment   $ 0   0    
Contract manufacturer deposit (non-interest bearing)   58,300,000   58,300,000    
Junos Pulse            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Proceeds from collection of notes receivable, principal $ 50,000,000.0          
Proceeds from collection of notes receivable, accrued interest 37,700,000          
Proceeds from collection of notes receivable $ 87,700,000          
Fair Value, Measurements, Recurring            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Financial and nonfinancial liabilities, fair value disclosure   2,200,000   2,200,000   $ 9,900,000
Fair Value, Measurements, Nonrecurring            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Financial and nonfinancial liabilities, fair value disclosure   0   0   0
Significant Other Unobservable Remaining Inputs (Level 3) | Fair Value, Measurements, Recurring            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Financial and nonfinancial liabilities, fair value disclosure   0   0   0
Significant Other Observable Remaining Inputs (Level 2)            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Total outstanding debt, fair value   1,984,000,000.0   1,984,000,000.0   1,852,100,000
Significant Other Observable Remaining Inputs (Level 2) | Fair Value, Measurements, Recurring            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Financial and nonfinancial liabilities, fair value disclosure   2,200,000   2,200,000   $ 9,900,000
Privately-held debt and redeemable preferred stock securities | Significant Other Unobservable Remaining Inputs (Level 3) | Fair Value, Measurements, Recurring            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Unrealized gain (loss) on investments   $ 0 $ 0 $ 0 $ 0  
v3.20.2
Derivative Instruments - Notional Amount (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Derivative [Line Items]    
Notional amount of derivatives $ 1,825,000,000.0 $ 946,900,000
Designated derivatives:    
Derivative [Line Items]    
Notional amount of derivatives 1,661,700,000 784,000,000.0
Non-designated derivatives    
Derivative [Line Items]    
Notional amount of derivatives 163,300,000 162,900,000
Foreign currency contracts | Cash flow hedges: | Designated derivatives:    
Derivative [Line Items]    
Notional amount of derivatives 711,700,000 484,000,000.0
Interest rate lock contracts | Cash flow hedges: | Designated derivatives:    
Derivative [Line Items]    
Notional amount of derivatives 650,000,000.0 0
Interest rate swap contracts | Fair value hedges: | Designated derivatives:    
Derivative [Line Items]    
Notional amount of derivatives $ 300,000,000.0 $ 300,000,000.0
v3.20.2
Derivative Instruments Fair Value of Derivative Assets and Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Derivative [Line Items]    
Derivative assets: $ 57.7 $ 2.5
Derivative liabilities: 2.2 9.9
Designated derivatives:    
Derivative [Line Items]    
Derivative assets: 57.6 2.5
Derivative liabilities: 2.0 9.7
Other current assets | Designated derivatives: | Foreign exchange contracts    
Derivative [Line Items]    
Derivative assets: 12.1 2.2
Other current assets | Non-designated derivatives    
Derivative [Line Items]    
Derivative assets: 0.1 0.0
Other accrued liabilities | Designated derivatives: | Foreign exchange contracts    
Derivative [Line Items]    
Derivative liabilities: 1.8 6.6
Other accrued liabilities | Non-designated derivatives    
Derivative [Line Items]    
Derivative liabilities: 0.2 0.2
Other long-term liabilities | Designated derivatives: | Foreign exchange contracts    
Derivative [Line Items]    
Derivative liabilities: 0.2 0.0
Other long-term liabilities | Designated derivatives: | Interest rate swap contracts    
Derivative [Line Items]    
Derivative liabilities: 0.0 3.1
Other long-term assets | Designated derivatives: | Foreign exchange contracts    
Derivative [Line Items]    
Derivative assets: 8.7 0.3
Other long-term assets | Designated derivatives: | Interest rate lock contracts    
Derivative [Line Items]    
Derivative assets: 10.9 0.0
Other long-term assets | Designated derivatives: | Interest rate swap contracts    
Derivative [Line Items]    
Derivative assets: $ 25.9 $ 0.0
v3.20.2
Derivative Instruments - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Derivatives, Notional Amount [Line Items]          
Notional amount of derivatives $ 1,825,000,000.0   $ 1,825,000,000.0   $ 946,900,000
Designated derivatives:          
Derivatives, Notional Amount [Line Items]          
Notional amount of derivatives 1,661,700,000   1,661,700,000   784,000,000.0
Cash flow hedges:          
Derivatives, Notional Amount [Line Items]          
Derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion 35,300,000 $ (12,400,000) $ 24,100,000 $ (11,100,000)  
Cash flow hedges: | Designated derivatives:          
Derivatives, Notional Amount [Line Items]          
Maximum maturities of cash flow hedge derivatives     36 months    
Losses expected to be reclassified into earnings within the next 12 months     $ 10,200,000    
Interest rate lock contracts | Cash flow hedges: | Designated derivatives:          
Derivatives, Notional Amount [Line Items]          
Notional amount of derivatives 650,000,000.0   $ 650,000,000.0   0
Swaps designated as cash flow hedges, expected termination period     5 years    
Interest rate swap contracts | Fair value hedges: | Designated derivatives:          
Derivatives, Notional Amount [Line Items]          
Notional amount of derivatives 300,000,000.0   $ 300,000,000.0   300,000,000.0
Foreign exchange contracts          
Derivatives, Notional Amount [Line Items]          
Foreign currency forward contracts, amounts reclassified out of AOCI (1,400,000) $ (800,000) (9,800,000) $ (1,500,000)  
Foreign exchange contracts | Cash flow hedges: | Designated derivatives:          
Derivatives, Notional Amount [Line Items]          
Notional amount of derivatives $ 711,700,000   $ 711,700,000   $ 484,000,000.0
Minimum | Foreign exchange contracts          
Derivatives, Notional Amount [Line Items]          
Maturity of foreign currency derivatives     1 month    
Maximum | Foreign exchange contracts          
Derivatives, Notional Amount [Line Items]          
Maturity of foreign currency derivatives     4 months    
Maximum | Interest rate swap contracts          
Derivatives, Notional Amount [Line Items]          
Derivative expiration period     9 years    
v3.20.2
Other Financial Information - Inventories, Net (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Schedule Of Inventory [Line Items]    
Production and service materials $ 144.6 $ 69.0
Finished goods 31.2 25.2
Inventory 175.8 94.2
Prepaid expenses and other current assets    
Schedule Of Inventory [Line Items]    
Inventory 166.4 90.6
Other long-term assets    
Schedule Of Inventory [Line Items]    
Inventory $ 9.4 $ 3.6
v3.20.2
Other Financial Information - Narrative (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2020
USD ($)
Sep. 30, 2020
USD ($)
Other Financial Information [Abstract]    
Contract manufacturer deposit (non-interest bearing) $ 58,300,000 $ 58,300,000
Non-interest bearing deposit to contract manufacturer, unamortized discount 3,000,000.0 $ 3,000,000.0
Non-interest bearing deposit to contract manufacturer, imputed interest rate   5.00%
Disaggregation of Revenue [Line Items]    
Deferred commission 26,200,000 $ 26,200,000
Amortization of deferred commission 35,100,000 92,700,000
Impairment loss 0 0
Product    
Disaggregation of Revenue [Line Items]    
Contract with customer, liability, revenue recognized 13,300,000 61,700,000
Service    
Disaggregation of Revenue [Line Items]    
Contract with customer, liability, revenue recognized $ 149,600,000 $ 622,600,000
v3.20.2
Other Financial Information - Warranties (Details)
$ in Millions
9 Months Ended
Sep. 30, 2020
USD ($)
Movement in Standard Product Warranty Accrual [Roll Forward]  
Balance as of December 31, 2019 $ 31.4
Provisions made during the period 28.1
Actual costs incurred during the period (28.9)
Balance as of September 30, 2020 $ 30.6
v3.20.2
Other Financial Information - Deferred Revenue (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Reported as:    
Current $ 750.2 $ 812.9
Long-term 383.8 410.5
Deferred revenue 1,134.0 1,223.4
Undelivered product commitments and other product deferrals    
Deferred product revenue:    
Deferred gross product revenue 109.8 141.7
Product    
Deferred product revenue:    
Deferred gross product revenue 109.8 141.7
Deferred cost of product revenue (10.5) (9.1)
Reported as:    
Deferred revenue 99.3 132.6
Service    
Reported as:    
Deferred revenue $ 1,034.7 $ 1,090.8
v3.20.2
Other Financial Information - Revenue (Details)
$ in Millions
Sep. 30, 2020
USD ($)
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 1,158.8
Product  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period 109.8
Service  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period 1,049.0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-10-01  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period 767.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-10-01 | Product  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 90.4
Revenue recognition expected by period, satisfaction period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-10-01 | Service  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 677.5
Revenue recognition expected by period, satisfaction period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 325.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01 | Product  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 17.3
Revenue recognition expected by period, satisfaction period 2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01 | Service  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 308.2
Revenue recognition expected by period, satisfaction period 2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 65.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01 | Product  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 2.1
Revenue recognition expected by period, satisfaction period
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01 | Service  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 63.3
Revenue recognition expected by period, satisfaction period
v3.20.2
Other Financial Information - Revenue - Total (Details)
$ in Millions
Sep. 30, 2020
USD ($)
Segment Reporting Information [Line Items]  
Revenue recognition expected by period $ 1,158.8
Product  
Segment Reporting Information [Line Items]  
Revenue recognition expected by period 109.8
Service  
Segment Reporting Information [Line Items]  
Revenue recognition expected by period $ 1,049.0
v3.20.2
Other Financial Information - Other Expense, Net (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Other Financial Information [Abstract]        
Interest income $ 6.1 $ 19.7 $ 30.4 $ 63.0
Interest expense (19.1) (22.1) (58.5) (68.3)
Loss on extinguishment of debt 0.0 (15.3) 0.0 (15.3)
Gain (loss) on investments, net 2.0 (3.4) 2.7 (4.6)
Other (2.5) 0.7 (3.6) 2.0
Other expense, net $ (13.5) $ (20.4) $ (29.0) $ (23.2)
v3.20.2
Restructuring Charges - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (benefits) $ 1.2 $ (1.1) $ 14.9 $ 35.6
2020 Restructuring Plan        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (benefits)     14.9  
2020 Restructuring Plan | Severance        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (benefits) $ 1.2   9.6  
2020 Restructuring Plan | Other Restructuring        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (benefits)     5.3  
Asset impairment charges     $ 5.3  
v3.20.2
Restructuring Charges - Changes to Restructuring Liabilities (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Restructuring Reserve [Roll Forward]        
Charges $ 1.2 $ (1.1) $ 14.9 $ 35.6
2020 Restructuring Plan        
Restructuring Reserve [Roll Forward]        
Restructuring liability, beginning balance     0.7  
Charges     14.9  
Cash Payments     (7.0)  
Other     (5.3)  
Restructuring liability, ending balance 3.3   3.3  
2020 Restructuring Plan | Severance        
Restructuring Reserve [Roll Forward]        
Restructuring liability, beginning balance     0.7  
Charges 1.2   9.6  
Cash Payments     (7.0)  
Other     0.0  
Restructuring liability, ending balance 3.3   3.3  
2020 Restructuring Plan | Other Restructuring        
Restructuring Reserve [Roll Forward]        
Restructuring liability, beginning balance     0.0  
Charges     5.3  
Cash Payments     0.0  
Other     (5.3)  
Restructuring liability, ending balance $ 0.0   $ 0.0  
v3.20.2
Debt - Schedule of Debt (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Long-term debt $ 1,700,000,000.0  
Unaccreted discount and debt issuance costs (11,800,000)  
Hedge accounting fair value adjustments 25,900,000  
Total 1,714,100,000  
Notional amount of derivatives 1,825,000,000.0 $ 946,900,000
Designated derivatives:    
Debt Instrument [Line Items]    
Notional amount of derivatives 1,661,700,000 784,000,000.0
Designated derivatives: | Fair value hedges: | Interest rate swap contracts    
Debt Instrument [Line Items]    
Notional amount of derivatives 300,000,000.0 $ 300,000,000.0
Senior notes | 4.500% fixed-rate notes (2024 Notes)    
Debt Instrument [Line Items]    
Long-term debt $ 350,000,000.0  
Effective interest rate 4.63%  
Stated interest rate 4.50%  
Senior notes | 4.500% fixed-rate notes (2024 Notes)    
Debt Instrument [Line Items]    
Long-term debt $ 150,000,000.0  
Effective interest rate 4.87%  
Stated interest rate 4.50%  
Senior notes | 4.350% fixed-rate notes ("2025 Notes")    
Debt Instrument [Line Items]    
Long-term debt $ 300,000,000.0  
Effective interest rate 4.47%  
Stated interest rate 4.35%  
Senior notes | 3.750% fixed-rate notes ("2029 Notes")    
Debt Instrument [Line Items]    
Long-term debt $ 500,000,000.0  
Effective interest rate 3.86%  
Stated interest rate 3.75%  
Senior notes | 5.950% fixed-rate notes ("2041 Notes")    
Debt Instrument [Line Items]    
Long-term debt $ 400,000,000.0  
Effective interest rate 6.03%  
Stated interest rate 5.95%  
v3.20.2
Debt - Revolving Credit Facility (Details)
9 Months Ended
Sep. 30, 2020
USD ($)
Line of Credit Facility [Line Items]  
Amount outstanding $ 1,714,100,000
Unsecured Revolving Credit Facility | Line of Credit  
Line of Credit Facility [Line Items]  
Borrowing capacity 500,000,000.0
Increase amount of borrowings, subject to lenders' approval $ 200,000,000.0
Extension option term 1 year
Amount outstanding $ 0
v3.20.2
Equity - Summary of Dividends Paid and Stock Repurchases and Retirements (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Jun. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dividends          
Per share (in dollars per share) $ 0.20 $ 0.19   $ 0.60 $ 0.57
Amount $ 66.2 $ 64.7   $ 197.9 $ 196.4
Repurchased under the 2018 Stock Repurchase Program          
Amount $ 100.4 111.1   345.7 $ 354.9
Forward contract under ASR   $ 60.0 $ 60.0 $ 40.0  
Stock Repurchase Program 2018          
Repurchased under the 2018 Stock Repurchase Program          
Shares (in shares) 4.2 5.1   14.5 13.7
Average price (in usd per share) $ 23.93 $ 24.90   $ 23.86 $ 25.45
Amount $ 100.0 $ 50.0   $ 300.0 $ 350.0
v3.20.2
Equity - Cash Dividends on Shares of Common Stock (Details) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Stockholders' Equity Note [Abstract]    
Cash dividends declared per share of common stock (in dollars per share) $ 0.20 $ 0.20
v3.20.2
Equity - Stock Repurchase Activities (Details) - USD ($)
$ / shares in Units, shares in Millions
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Oct. 31, 2019
Sep. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Mar. 31, 2020
Sep. 30, 2020
Sep. 30, 2019
Jan. 31, 2018
Accelerated Share Repurchases [Line Items]                  
Payment pursuant to ASR             $ 305,700,000 $ 354,900,000  
Common stock received, aggregate price   $ 100,400,000     $ 111,100,000   $ 345,700,000 $ 354,900,000  
Stock Repurchase Program 2018                  
Accelerated Share Repurchases [Line Items]                  
Stock repurchase program, authorized amount $ 3,000,000,000.0               $ 2,000,000,000.0
Stock repurchase program, increase to authorized amount 1,000,000,000.0                
Stock repurchased and retired (in shares)   4.2     5.1   14.5 13.7  
Common stock received, aggregate price   $ 100,000,000.0     $ 50,000,000.0   $ 300,000,000.0 $ 350,000,000.0  
Stock repurchased (in shares)             14.5    
Common stock repurchased, average cost per share (in dollars per share)             $ 23.86    
Stock repurchase program, remaining authorized repurchase amount   $ 1,400,000,000         $ 1,400,000,000    
Accelerated Share Repurchase Program                  
Accelerated Share Repurchases [Line Items]                  
Stock repurchase program, authorized amount $ 200,000,000.0                
Payment pursuant to ASR       $ 200,000,000.0          
Stock repurchased and retired (in shares)     1.8 6.4   8.2      
Common stock received, aggregate price       $ 160,000,000.0          
Common stock repurchased under stock repurchase program market price (in usd per share)       $ 25.15          
Weighted average repurchase price, stock repurchased and retired during period (in usd per share)     $ 24.44            
v3.20.2
Equity - Components of Accumulated Other Comprehensive (Loss) Income, Net of Tax (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance $ 4,464.3 $ 4,591.2 $ 4,610.6 $ 4,823.2
Other comprehensive loss before reclassifications     25.7  
Amount reclassified from accumulated other comprehensive loss     8.0  
Other comprehensive loss, net 38.1 (15.5) 33.7 (8.6)
Balance 4,560.8 4,642.4 4,560.8 4,642.4
Accumulated Other Comprehensive Loss        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance (22.9) (11.3) (18.5) (18.2)
Balance 15.2 $ (26.8) 15.2 $ (26.8)
Unrealized Gains/Losses on Available-for- Sale Debt Securities        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance     29.7  
Other comprehensive loss before reclassifications     6.2  
Amount reclassified from accumulated other comprehensive loss     (0.5)  
Other comprehensive loss, net     5.7  
Balance 35.4   35.4  
Unrealized Gains/Losses on Cash Flow Hedges        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance     (4.3)  
Other comprehensive loss before reclassifications     21.0  
Amount reclassified from accumulated other comprehensive loss     8.5  
Other comprehensive loss, net     29.5  
Balance 25.2   25.2  
Foreign Currency Translation Adjustments        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance     (43.9)  
Other comprehensive loss before reclassifications     (1.5)  
Amount reclassified from accumulated other comprehensive loss     0.0  
Other comprehensive loss, net     (1.5)  
Balance $ (45.4)   $ (45.4)  
v3.20.2
Employee Benefit Plans - Equity Incentive Plan (Details)
shares in Millions
Sep. 30, 2020
shares
Equity incentive plan 2015  
Share-Based Compensation Plans  
Number of shares available for future issuance (in shares) 12.4
Employee stock purchase plan 2008  
Share-Based Compensation Plans  
Number of shares available for future issuance (in shares) 11.5
v3.20.2
Employee Benefit Plans - Restricted Stock Unit and Performance Share Award Activities (Details)
$ / shares in Units, shares in Millions, $ in Millions
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Service-based RSUs  
Number of Shares  
Granted (in shares) 6.2
RSUs, RSAs, and PSAs  
Number of Shares  
Balance at beginning of period (in shares) 17.5
Granted (in shares) 7.4
Vested (in shares) (5.9)
Canceled (in shares) (2.0)
Balance at end of period (in shares) 17.0
Weighted Average Grant-Date Fair Value per Share  
Balance at beginning of period (in dollars per share) | $ / shares $ 25.30
Granted (in dollars per share) | $ / shares 22.32
Vested (in dollars per share) | $ / shares 25.95
Canceled (in dollars per share) | $ / shares 25.22
Balance at end of period (in dollars per share) | $ / shares $ 23.79
Weighted average remaining contractual term 1 year 2 months 12 days
Aggregate intrinsic value | $ $ 364.9
Performance Shares  
Number of Shares  
Granted (in shares) 0.8
Market-based RSUs  
Number of Shares  
Granted (in shares) 0.4
v3.20.2
Employee Benefit Plans - Employee Stock Purchase Plan (Details)
shares in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
period
$ / shares
shares
Sep. 30, 2019
$ / shares
shares
Sep. 30, 2020
period
$ / shares
shares
Sep. 30, 2019
$ / shares
shares
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]        
ESPP offering period duration     24 months  
ESPP, number of purchase period | period 4   4  
ESPP. purchase period     6 months  
ESPP, purchase price of common stock, percent     85.00%  
Employee stock purchase plan 2008        
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]        
Shares purchased (in shares) | shares 1.3 1.2 2.7 2.4
Average exercise price per share (in dollars per share) | $ / shares $ 19.68 $ 22.03 $ 19.59 $ 22.04
v3.20.2
Employee Benefit Plans - Share Based Compensation by Cost and Expense Categories (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Stock Based Compensation Expense Recorded in Cost and Expense Categories        
Share-based compensation expense $ 52.7 $ 57.5 $ 138.7 $ 147.1
Stock options        
Stock Based Compensation Expense Recorded in Cost and Expense Categories        
Share-based compensation expense 1.5 2.3 5.2 5.6
RSUs, RSAs, and PSAs        
Stock Based Compensation Expense Recorded in Cost and Expense Categories        
Share-based compensation expense 45.8 50.9 118.0 127.7
ESPP        
Stock Based Compensation Expense Recorded in Cost and Expense Categories        
Share-based compensation expense 5.4 4.3 15.5 13.8
Cost of revenues - Product        
Stock Based Compensation Expense Recorded in Cost and Expense Categories        
Share-based compensation expense 1.4 0.8 3.9 4.3
Cost of revenues - Service        
Stock Based Compensation Expense Recorded in Cost and Expense Categories        
Share-based compensation expense 4.0 4.1 11.6 13.0
Research and development        
Stock Based Compensation Expense Recorded in Cost and Expense Categories        
Share-based compensation expense 22.9 29.6 57.1 68.0
Sales and marketing        
Stock Based Compensation Expense Recorded in Cost and Expense Categories        
Share-based compensation expense 16.4 15.5 43.4 40.0
General and administrative        
Stock Based Compensation Expense Recorded in Cost and Expense Categories        
Share-based compensation expense $ 8.0 $ 7.5 $ 22.7 $ 21.8
v3.20.2
Employee Benefit Plans - Share Based Compensation by Share Based Payment Award Types (Details)
$ in Millions
9 Months Ended
Sep. 30, 2020
USD ($)
Share-based Payment Arrangement [Abstract]  
Unrecognized compensation cost $ 288.4
Unrecognized compensation, weighted average recognition period 1 year 8 months 4 days
v3.20.2
Segments - Revenue by Product (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
segment
Sep. 30, 2019
USD ($)
Segment Reporting Information [Line Items]        
Number of reportable segments | segment     1  
Total net revenues $ 1,138.2 $ 1,133.1 $ 3,222.5 $ 3,237.3
Product        
Segment Reporting Information [Line Items]        
Total net revenues 733.7 743.2 2,034.8 2,075.8
Routing        
Segment Reporting Information [Line Items]        
Total net revenues 432.0 407.5 1,149.7 1,199.1
Switching        
Segment Reporting Information [Line Items]        
Total net revenues 229.0 241.6 657.6 633.6
Security        
Segment Reporting Information [Line Items]        
Total net revenues 72.7 94.1 227.5 243.1
Service        
Segment Reporting Information [Line Items]        
Total net revenues $ 404.5 $ 389.9 $ 1,187.7 $ 1,161.5
v3.20.2
Segments - Revenues by Customer Vertical (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Segment Reporting Information [Line Items]        
Total net revenues $ 1,138.2 $ 1,133.1 $ 3,222.5 $ 3,237.3
Cloud        
Segment Reporting Information [Line Items]        
Total net revenues 253.1 271.9 800.5 780.0
Service Provider        
Segment Reporting Information [Line Items]        
Total net revenues 475.1 452.5 1,286.8 1,335.3
Enterprise        
Segment Reporting Information [Line Items]        
Total net revenues $ 410.0 $ 408.7 $ 1,135.2 $ 1,122.0
v3.20.2
Segments - Geographic (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Segment Reporting Information [Line Items]        
Total net revenues $ 1,138.2 $ 1,133.1 $ 3,222.5 $ 3,237.3
Total Americas        
Segment Reporting Information [Line Items]        
Total net revenues 624.3 648.8 1,812.6 1,841.2
United States        
Segment Reporting Information [Line Items]        
Total net revenues 575.0 599.4 1,651.7 1,677.2
Other        
Segment Reporting Information [Line Items]        
Total net revenues 49.3 49.4 160.9 164.0
Europe, Middle East, and Africa        
Segment Reporting Information [Line Items]        
Total net revenues 321.1 301.5 870.2 879.6
Asia Pacific        
Segment Reporting Information [Line Items]        
Total net revenues $ 192.8 $ 182.8 $ 539.7 $ 516.5
v3.20.2
Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 22, 2020
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Tax Contingency [Line Items]          
Income before income taxes   $ 111.6 $ 118.1 $ 226.0 $ 240.4
Income tax (benefit) provision   $ (33.8) $ 18.8 $ (1.0) $ 63.8
Effective tax rate   (30.30%) 15.90% (0.40%) 26.50%
Unrecognized tax benefits   $ 112.2   $ 112.2  
Interest and penalties   18.4   18.4  
Cumulative impact of cost sharing for stock-based compensation $ 18.2        
India tax authority          
Income Tax Contingency [Line Items]          
Unrecognized tax benefits   54.5   54.5  
Maximum          
Income Tax Contingency [Line Items]          
Unrecognized tax benefits, maximum decrease in the next twelve months   $ 11.6   $ 11.6  
v3.20.2
Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Numerator:        
Net income $ 145.4 $ 99.3 $ 227.0 $ 176.6
Denominator:        
Weighted-average shares used to compute basic net income per share (in shares) 330.9 342.2 330.9 345.5
Dilutive effect of employee stock awards (in shares) 3.6 3.3 4.3 4.6
Weighted-average shares used to compute diluted net income per share (in shares) 334.5 345.5 335.2 350.1
Net income per share        
Basic (in dollars per share) $ 0.44 $ 0.29 $ 0.69 $ 0.51
Diluted, (in dollars per share) $ 0.43 $ 0.29 $ 0.68 $ 0.50
Anti-dilutive shares (in shares) 3.4 2.8 5.5 2.7
v3.20.2
Commitments and Contingencies - Commitments (Details)
$ in Millions
Sep. 30, 2020
USD ($)
Loss Contingencies [Line Items]  
Purchase obligation $ 1,402.5
Excess purchase commitments and obsolete materials liability 18.5
Master Service Agreement  
Loss Contingencies [Line Items]  
Reduction in fees payable $ 79.4
v3.20.2
Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 27, 2020
Oct. 26, 2020
Oct. 31, 2020
Sep. 30, 2020
Sep. 30, 2020
Subsequent Event [Line Items]          
Cash dividends declared per share of common stock (in dollars per share)       $ 0.20 $ 0.20
Subsequent Event          
Subsequent Event [Line Items]          
Cash dividends declared per share of common stock (in dollars per share) $ 0.20        
Subsequent Event | 128 Technology          
Subsequent Event [Line Items]          
Consideration transferred, cash     $ 450.0    
Subsequent Event | Netrounds          
Subsequent Event [Line Items]          
Consideration transferred, cash   $ 35.0